<!DOCTYPE art SYSTEM "article.dtd">
<art>
   <ui>scrt113</ui>
   <ji>1757-6512</ji>
   <fm>
      <dochead>Research</dochead>
      <bibl>
         <title>
            <p><it>SOX9 </it>gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells</p>
         </title>
         <aug>
            <au id="A1" ce="yes">
               <snm>Venkatesan</snm>
               <mi>K</mi>
               <fnm>Jagadeesh</fnm>
               <insr iid="I1"/>
               <email>jegadish.venki@gmail.com</email>
            </au>
            <au id="A2" ce="yes">
               <snm>Ekici</snm>
               <fnm>Myriam</fnm>
               <insr iid="I1"/>
               <email>myriamekici@web.de</email>
            </au>
            <au id="A3">
               <snm>Madry</snm>
               <fnm>Henning</fnm>
               <insr iid="I1"/>
               <insr iid="I2"/>
               <email>henning.madry@uks.eu</email>
            </au>
            <au id="A4">
               <snm>Schmitt</snm>
               <fnm>Gertrud</fnm>
               <insr iid="I1"/>
               <email>gertrud.schmitt@uniklinikum-saarland.de</email>
            </au>
            <au id="A5">
               <snm>Kohn</snm>
               <fnm>Dieter</fnm>
               <insr iid="I2"/>
               <email>dieter.kohn@uks.eu</email>
            </au>
            <au id="A6" ca="yes">
               <snm>Cucchiarini</snm>
               <fnm>Magali</fnm>
               <insr iid="I1"/>
               <email>mmcucchiarini@hotmail.com</email>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Center of Experimental Orthopaedics, Saarland University Medical Center, Kirrbergerstr. Bldg 37, Homburg/Saar, D-66421 Germany</p>
            </ins>
            <ins id="I2">
               <p>Department of Orthopaedic Surgery, Saarland University Medical Center, Kirrbergerstr. Bldg 37, Homburg/Saar, D-66421 Germany</p>
            </ins>
         </insg>
         <source>Stem Cell Research &amp; Therapy</source>
         <issn>1757-6512</issn>
         <pubdate>2012</pubdate>
         <volume>3</volume>
         <issue>3</issue>
         <fpage>22</fpage>
         <url>http://stemcellres.com/content/3/3/22</url>
         <xrefbib>
            <pubidlist>
               <pubid idtype="doi">10.1186/scrt113</pubid>
               <pubid idtype="pmpid">22742415</pubid>
            </pubidlist>
         </xrefbib>
      </bibl>
      <history>
         <rec>
            <date>
               <day>21</day>
               <month>5</month>
               <year>2012</year>
            </date>
         </rec>
         <acc>
            <date>
               <day>28</day>
               <month>6</month>
               <year>2012</year>
            </date>
         </acc>
         <pub>
            <date>
               <day>28</day>
               <month>6</month>
               <year>2012</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2012</year>
         <collab>Venkatesan et al.; licensee BioMed Central Ltd.</collab>
         <note>This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note>
      </cpyrt>
      <abs>
         <sec>
            <st>
               <p>Abstract</p>
            </st>
            <sec>
               <st>
                  <p>Introduction</p>
               </st>
               <p>Transplantation of genetically modified human bone marrow-derived mesenchymal stem cells (hMSCs) with an accurate potential for chondrogenic differentiation may be a powerful means to enhance the healing of articular cartilage lesions in patients. Here, we evaluated the benefits of delivering <it>SOX9 </it>(a key regulator of chondrocyte differentiation and cartilage formation) via safe, maintained, replication-defective recombinant adeno-associated virus (rAAV) vector on the capability of hMSCs to commit to an adequate chondrocyte phenotype compared with other mesenchymal lineages.</p>
            </sec>
            <sec>
               <st>
                  <p>Methods</p>
               </st>
               <p>The rAAV-FLAG-h<it>SOX9 </it>vector was provided to both undifferentiated and lineage-induced MSCs freshly isolated from patients to determine the effects of the candidate construct on the viability, biosynthetic activities, and ability of the cells to enter chondrogenic, osteogenic, and adipogenic differentiation programs compared with control treatments (rAAV-<it>lacZ </it>or absence of vector administration).</p>
            </sec>
            <sec>
               <st>
                  <p>Results</p>
               </st>
               <p>Marked, prolonged expression of the transcription factor was noted in undifferentiated and chondrogenically differentiated cells transduced with rAAV-FLAG-h<it>SOX9</it>, leading to increased synthesis of major extracellular matrix components compared with control treatments, but without effect on proliferative activities. Chondrogenic differentiation (<it>SOX9</it>, type II collagen, proteoglycan expression) was successfully achieved in all types of cells but strongly enhanced when the <it>SOX9 </it>vector was provided. Remarkably, rAAV-FLAG-h<it>SOX9 </it>delivery reduced the levels of markers of hypertrophy, terminal and osteogenic/adipogenic differentiation in hMSCs (type I and type X collagen, alkaline phosphatise (ALP), matrix metalloproteinase 13 (MMP13), and osteopontin (OP) with diminished expression of the osteoblast-related transcription factor runt-related transcription factor 2 (RUNX2); lipoprotein lipase (LPL), peroxisome proliferator-activated receptor gamma 2 (PPARG2)), as well as their ability to undergo proper osteo-/adipogenic differentiation. These effects were accompanied with decreased levels of &#946;-catenin (a mediator of the Wnt signaling pathway for osteoblast lineage differentiation) and enhanced parathyroid hormone-related protein (PTHrP) expression (an inhibitor of hypertrophic maturation, calcification, and bone formation) via <it>SOX9 </it>treatment.</p>
            </sec>
            <sec>
               <st>
                  <p>Conclusions</p>
               </st>
               <p>This study shows the potential benefits of rAAV-mediated <it>SOX9 </it>gene transfer to propagate hMSCs with an advantageous chondrocyte differentiation potential for future, indirect therapeutic approaches that aim at restoring articular cartilage defects in the human population.</p>
            </sec>
         </sec>
      </abs>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Introduction</p>
         </st>
         <p>Adult hyaline articular cartilage that allows smooth gliding and weight-bearing on articulating surfaces is an aneural and avascular tissue, lacking a lymphatic drainage. As a consequence, articular cartilage does not have access to reparative cells brought in other tissues in response to injury, and articular cartilage defects become persistent and progress over time after trauma or degeneration. The chondrocytes are the only cells present in the articular cartilage, producing and surrounding themselves with an intricate network of extracellular matrix composed mostly of proteoglycans and type II collagen that is largely deteriorated in cartilage lesions. Despite several currently available surgical options, restoration of a native structure and phenotype in injured articular cartilage is difficult to achieve, as only a poorly organized repair tissue made of type I collagen is produced, which does not totally integrate with the surrounding cartilage and does not withstand mechanical stress over time.</p>
         <p>The principle of transplanting progenitor cells like mesenchymal stem cells (MSCs) to improve the regenerative properties of the articular cartilage is an attractive approach to enhance the natural healing response of damaged tissue <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. MSCs have a strong potential for self-renewal and differentiation into various cell lineages, among which are the chondrocytes. They can be easily isolated and propagated, may recapitulate lineage transitions originally involved in tissue formation, and might be better suited than differentiated cells, such as chondrocytes, that tend to lose their phenotype on expansion. Although MSCs have been safely applied in patients to treat articular cartilage defects and osteoarthritis <abbrgrp><abbr bid="B2">2</abbr><abbr bid="B3">3</abbr></abbrgrp> without signs of tumorigenicity or immunologic reactions, their use is still impeded by the low percentage of cells that undergo functional differentiation programs to produce adequate reparative tissues. Specifically, for articular cartilage repair, the important challenge when implanting MSCs will be to maintain the MSC-derived cells in a non-hypertrophic state that avoids premature terminal differentiation, hypertrophy, and ossification <abbrgrp><abbr bid="B4">4</abbr><abbr bid="B5">5</abbr></abbrgrp>.</p>
         <p>In this regard, gene-transfer methods might provide powerful tools to overcome such limitations by precisely and durably improving the intrinsic chondrogenic potential of MSCs for strategies that aim at enhancing articular cartilage repair. Different factors have been reported for their ability to direct MSCs toward the chondrocyte phenotype. They include the transforming growth factor beta (TGF-&#946;) <abbrgrp><abbr bid="B6">6</abbr><abbr bid="B7">7</abbr><abbr bid="B8">8</abbr><abbr bid="B9">9</abbr><abbr bid="B10">10</abbr><abbr bid="B11">11</abbr></abbrgrp>, bone morphogenic proteins (BMPs) <abbrgrp><abbr bid="B9">9</abbr><abbr bid="B10">10</abbr><abbr bid="B12">12</abbr><abbr bid="B13">13</abbr></abbrgrp>, the insulin-like growth factor I (IGF-I) <abbrgrp><abbr bid="B14">14</abbr><abbr bid="B15">15</abbr></abbrgrp>, basic fibroblast growth factor (FGF-2) <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B17">17</abbr></abbrgrp>, zinc-finger protein 145 (ZNF145) <abbrgrp><abbr bid="B18">18</abbr></abbrgrp>, human telomerase (hTERT) <abbrgrp><abbr bid="B19">19</abbr><abbr bid="B20">20</abbr></abbrgrp>, and the antiapoptotic factor Bcl-xL <abbrgrp><abbr bid="B21">21</abbr></abbrgrp>. Yet, the use of these agents remains disputable, as most of them do not promote the synthesis of specific cartilage matrix components <it>per se </it>(FGF-2, hTERT, Bcl-xL) <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B19">19</abbr><abbr bid="B20">20</abbr><abbr bid="B21">21</abbr></abbrgrp> or an adequate chondrogenic differentiation (IGF-I) <abbrgrp><abbr bid="B15">15</abbr></abbrgrp>, or even lead to undesirable MSC hypertrophy (TGF-&#946;, BMPs) <abbrgrp><abbr bid="B7">7</abbr><abbr bid="B10">10</abbr><abbr bid="B13">13</abbr><abbr bid="B15">15</abbr></abbrgrp>. In this regard, members of the sex-determining region Y-type high-mobility group box (SOX) family of transcription factors might be better candidates to refine chondrogenesis in MSCs. Especially SOX9 plays central roles in chondrocyte differentiation and cartilage formation <abbrgrp><abbr bid="B22">22</abbr></abbrgrp> and has been reported for its inhibitory or delaying effects on terminal differentiation and hypertrophy <abbrgrp><abbr bid="B23">23</abbr><abbr bid="B24">24</abbr><abbr bid="B25">25</abbr><abbr bid="B26">26</abbr><abbr bid="B27">27</abbr></abbrgrp>, although recent evidence demonstrated that the impact of SOX9 might be different for postdifferentiation chondrocytes <abbrgrp><abbr bid="B28">28</abbr><abbr bid="B29">29</abbr></abbrgrp>. Interestingly, systems used to deliver <it>SOX </it>sequences to MSCs so far have been based on the use of nonviral <abbrgrp><abbr bid="B26">26</abbr><abbr bid="B30">30</abbr></abbrgrp> and classic virus-derived constructs, including adenoviral <abbrgrp><abbr bid="B24">24</abbr><abbr bid="B31">31</abbr><abbr bid="B32">32</abbr></abbrgrp> and retro-/lentiviral vectors <abbrgrp><abbr bid="B33">33</abbr></abbrgrp>. They display low (nonviral and retroviral vectors) and transient (nonviral and adenoviral vectors) gene-transfer efficiencies, tend to induce host immune responses (adenoviral vectors), or promote insertional mutagenesis (retroviral vectors). Vectors such as those generated from the nonpathogenic, replication-defective adenoassociated virus (AAV), instead, have considerable advantages for gene-transfer protocols in MSCs. Recombinant AAV (rAAV) has been shown to transduce these cells at very high efficiencies and over sufficient periods without impairing their differentiation potential <abbrgrp><abbr bid="B8">8</abbr><abbr bid="B16">16</abbr><abbr bid="B34">34</abbr></abbrgrp>. They can be safely used because of the removal of potentially immunogenic viral sequences in the recombinant genome and may avoid the risk for insertional mutagenesis by being kept in stable episomal forms in the host, making rAAV an adapted system for experimental settings <it>in vivo </it><abbrgrp><abbr bid="B8">8</abbr><abbr bid="B35">35</abbr></abbrgrp> and for clinical protocols <abbrgrp><abbr bid="B36">36</abbr></abbrgrp>.</p>
         <p>In the present study, we examined the efficacy of rAAV to deliver an <it>SOX9 </it>gene sequence, a key regulator of chondrogenesis, to primary adult human MSCs isolated from patients, the ultimate targets for clinical applications. We also determined the effects of the candidate treatment on the proliferative, metabolic, and differentiative (chondrogenic versus osteo-/adipogenic) activities of these cells as a prelude for future evaluations <it>in vivo </it>to enhance articular cartilage repair by implanting such genetically modified progenitor cells in cartilage defects.</p>
      </sec>
      <sec>
         <st>
            <p>Materials and methods</p>
         </st>
         <sec>
            <st>
               <p>Reagents</p>
            </st>
            <p>Reagents were from Sigma (Munich, Germany) unless otherwise indicated. Recombinant FGF-2 (rFGF-2) and TGF-&#946; were purchased at R&amp;D Systems (Wiesbaden-Nordenstadt, Germany). The dimethylmethylene blue dye was from Serva (Heidelberg, Germany). The anti-type I (AF-5610) and anti-type II collagen (AF-5710) antibodies were from Acris (Hiddenhausen, Germany), the anti-FLAG (BioM2) and anti-type X collagen (COL-10) antibodies from Sigma, and the anti-SOX9 (C-20), anti-CD34 (C-18), anti-CD71 (C-20), and anti-CD105 (T-20) antibodies from Santa Cruz Biotechnology (Heidelberg, Germany). Biotinylated secondary antibodies and ABC reagent were from Vector Laboratories (Alexis Deutschland GmbH, Gr&#252;nberg, Germany). The Cell Proliferation reagent WST-1 was from Roche Applied Science (Mannheim, Germany). The type II and type I collagen enzyme-linked immunosorbent assays (ELISAs; Arthrogen-CIA Capture ELISA kit) were from Chondrex (Redmond, WA, USA), and the type X collagen ELISA (COL-10) from Antibodies-online GmbH (Aachen, Germany). The alkaline phosphatase (ALP) activity detection assay (QuantiChrom ALP Kit) was from BioAssay Systems (Biotrend Chemikalien GmbH, Cologne, Germany).</p>
         </sec>
         <sec>
            <st>
               <p>Cell culture</p>
            </st>
            <p>Bone marrow aspirates (~15 ml) were obtained from the distal femurs of patients undergoing total knee arthroplasty (<it>n </it>= 28). The study was approved by the Ethics Committee of the Saarland Physicians Council. All patients provided informed consent before inclusion in the study. All procedures were in accordance with the Helsinki Declaration. Mesenchymal stem cells (MSCs) were isolated and expanded in culture by using standard protocols <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B37">37</abbr><abbr bid="B38">38</abbr></abbrgrp>. Aspirates were washed in DMEM, and the cell-containing fractions layered onto Histopaque-1077 density gradient and centrifuged at 800 <it>g </it>for 30 minutes at room temperature. The nucleated cell fraction at the interface was collected, washed, and resuspended in Mesencult Basal Medium containing MSC Stimulatory Supplements (StemCell Technologies, Cologne, Germany) with 100 U/ml penicillin and 100 &#956;l/ml streptomycin (pen-strep) (basal medium) and rFGF-2 (10 ng/ml). MSCs were plated at 2 &#215; 10<sup>5 </sup>cells/cm<sup>2 </sup>in T-75 flasks and maintained at 37&#176;C in a humidified atmosphere with 5% CO<sub>2</sub>. The medium was exchanged after 48 hours and every 2 to 3 days thereafter. Cells were detached and replated for further experiments at appropriate densities. MSCs were analyzed with flow cytometry for expression of stem-cell surface markers (CD71<sup>+</sup>, CD105<sup>+</sup>, CD34<sup>-</sup>). All experiments were performed with cells at not more than passage two.</p>
         </sec>
         <sec>
            <st>
               <p>Plasmids and rAAV vectors</p>
            </st>
            <p>The constructs were all derived from the same parental AAV-2 genomic clone, pSSV9 <abbrgrp><abbr bid="B39">39</abbr><abbr bid="B40">40</abbr></abbrgrp>. rAAV-<it>lacZ </it>is an AAV-2-based vector plasmid carrying the <it>lacZ </it>gene encoding &#946;-galactosidase (&#946;-Gal) under the control of the cytomegalovirus immediate-early (CMV-IE) promoter <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. rAAV-FLAG-h<it>SOX9 </it>is the same AAV-2-based vector plasmid used to prepare rAAV-<it>lacZ </it>but carrying a FLAG-tagged <it>SOX9 </it>sequence (1.7 kb) <abbrgrp><abbr bid="B45">45</abbr></abbrgrp> instead of <it>lacZ </it><abbrgrp><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr></abbrgrp>. All rAAVs were packaged as conventional (not self-complementary) vectors in the 293 cell line, an adenovirus-transformed human embryonic kidney cell line, by using Adenovirus 5 to provide helper functions in combination with the <it>trans</it>-acting AAV-2 factors for replication and encapsidation functions supplied by the pAd8 helper plasmid <abbrgrp><abbr bid="B40">40</abbr></abbrgrp>. Potential contamination from Adenovirus was prevented by heating and purification, as previously described <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. The preparations were dialyzed and titered with real-time PCR <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>, averaging 10<sup>11 </sup>functional units/ml (that is, 10<sup>12 </sup>viral genomes/ml).</p>
         </sec>
         <sec>
            <st>
               <p>rAAV-mediated gene transfer</p>
            </st>
            <p>Monolayer cultures of undifferentiated hMSCs (4 &#215; 10<sup>4 </sup>cells) were transduced with rAAV (40 &#956;l vector) or left untreated <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp> and kept in basal medium for up to 21 days. hMSC aggregate cultures (2 &#215; 10<sup>5 </sup>cells) were prepared <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B37">37</abbr><abbr bid="B38">38</abbr></abbrgrp> and kept in DMEM high glucose (4.5 g/L), pen-strep, ITS<sup>+ </sup>Premix (insulin, 6.25 &#956;g/ml; transferring, 6.25 &#956;g/ml; selenous acid, 6.25 &#956;g/ml; linoleic acid, 5.35 &#956;g/ml; bovine serum albumin, 1.25 &#956;g/ml), pyruvate (1 m<it>M</it>), ascorbate 2-phosphate (37.5 &#956;g/ml), dexamethasone (10<sup>-7 </sup><it>M</it>), and TGF-&#946; (10 ng/ml) (defined medium) at 37&#176;C in a humidified atmosphere with 5% CO<sub>2</sub>. The cells formed a free-floating mass within 24 hours that was transduced with rAAV (100 &#956;l vector) 1 day after aggregate formation (or left untreated) and kept in defined medium for up to 21 days <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. For osteogenic and adipogenic differentiation, hMSCs in monolayer cultures (10<sup>5 </sup>cells) were transduced with rAAV (100 &#956;l vector) or left untreated, and induced toward osteogenic differentiation by using the StemPro Osteogenesis Differentiation kit (Life Technologies GmbH, Darmstadt, Germany) or adipogenic differentiation by using the StemPro Adipogenesis Differentiation kit (Life Technologies GmbH) for up to 21 days at 37&#176;C in a humidified atmosphere with 5% CO<sub>2 </sub><abbrgrp><abbr bid="B38">38</abbr><abbr bid="B46">46</abbr><abbr bid="B47">47</abbr></abbrgrp>.</p>
         </sec>
         <sec>
            <st>
               <p>Histology, immunocyto-, and immunohistochemistry</p>
            </st>
            <p>Monolayer and aggregate cultures were harvested and fixed in 10% buffered formalin. Aggregates were dehydrated in graded alcohols, embedded in paraffin, and sectioned (5 &#956;m). Samples were processed for transgene expression by immunocytochemical and immunohistochemical analyses using specific antibodies. Sections were also stained with H&amp;E (cellularity), toluidine blue (matrix proteoglycans), and alizarin red (matrix mineralization) according to routine protocols. Expression of type I, type II, and type X collagen was detected by immunohistochemistry by using specific antibodies, biotinylated secondary antibodies, and the ABC method with diaminobenzidine (DAB) as the chromogen <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B37">37</abbr><abbr bid="B38">38</abbr></abbrgrp>. To control for secondary immunoglobulins, samples were processed with omission of the primary antibody. Osteogenically differentiated cultures were stained for ALP (Alkaline Phosphatase staining kit, Sigma), and adipogenically differentiated cultures for intracellular lipid droplets with Oil Red O (Sigma) <abbrgrp><abbr bid="B38">38</abbr><abbr bid="B46">46</abbr><abbr bid="B47">47</abbr></abbrgrp>. Samples were examined with light microscopy (Olympus BX 45, Hamburg, Germany).</p>
         </sec>
         <sec>
            <st>
               <p>Histomorphometry</p>
            </st>
            <p>The intensities of SOX9 immunostaining and the percentages of areas stained for ALP or Oil Red O were calculated as being the ratios of positively stained surface to the total surface evaluated. The cell numbers and viability were monitored with trypan blue exclusion and by counting cells on H&amp;E-stained sections from aggregates <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. The intensities of SOX9 immunostaining, transduction efficiencies (X-Gal staining), aggregate diameters, cell densities, intensities of toluidine blue and of alizarin red staining, and those of type I, type II, and type X collagen immunostaining were measured at three standardized sites or by using 10 serial histologic and immunohistochemical sections for each parameter, test, and replicate condition by using SIS AnalySIS (Olympus), Adobe Photoshop (Adobe Systems, Unterschleissheim, Germany), and Scion Image (Scion Corporation, Frederick, MD, USA) <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. The toluidine blue staining intensities were in pixels per area, and those for alizarin red staining, type I, type II, and type X collagen immunostaining in percentages, representing the ratios of positively stained tissue surface to the total surface of the site evaluated.</p>
         </sec>
         <sec>
            <st>
               <p>Biochemical assays</p>
            </st>
            <p>Cultures were harvested with selective papain digestion for aggregates. Cell proliferation was assessed with the Cell Proliferation reagent WST-1 <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B44">44</abbr></abbrgrp>. The DNA contents were determined with a fluorimetric assay by using Hoechst 33258 <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. The proteoglycan contents were measured by binding to dimethylmethylene blue dye <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B35">35</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>, and those for type I, type II, and type X collagen with ELISA <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B41">41</abbr><abbr bid="B42">42</abbr><abbr bid="B43">43</abbr><abbr bid="B44">44</abbr></abbrgrp>. The ALP activities were analyzed with a colorimetric assay to measure the hydrolysis of <it>p</it>-nitrophenol by using a standard curve made of this reagent <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. All measurements were performed by using a GENios spectrophotometer/fluorometer (Tecan, Crailsheim, Germany).</p>
         </sec>
         <sec>
            <st>
               <p>Total RNA extraction and real-time RT-PCR analyses</p>
            </st>
            <p>Total cellular RNA was extracted from the cultures by using the RNeasy Protect Mini Kit with an on-column RNase-free DNase treatment (Qiagen, Hilden, Germany) <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B37">37</abbr><abbr bid="B46">46</abbr></abbrgrp>. RNA was eluted in 30 &#956;l RNase-free water. Reverse transcription was carried out with 8 &#956;l of eluate by using the 1<sup>st </sup>Strand cDNA Synthesis kit for RT-PCR (AMV) (Roche Applied Science). An aliquot of the cDNA product (2 &#956;l) was amplified with real-time PCR by using the Brilliant SYBR Green QPCR Master Mix (Stratagene, Agilent Technologies, Waldbronn, Germany) <abbrgrp><abbr bid="B16">16</abbr></abbrgrp> on an Mx3000P QPCR operator system (Stratagene) as follows: (95&#176;C, 10 minutes), amplification by 40 cycles (denaturation at 95&#176;C, 30 seconds; annealing at 55&#176;C, 1 minute; extension at 72&#176;C, 30 seconds), denaturation (95&#176;C, 1 minute), and final incubation (55&#176;C, 30 seconds). The primers (Invitrogen GmbH) used were SOX9 (chondrogenic marker) (forward 5'-ACACACAGCTCACTCGACCTTG-3'; reverse 5'-GGGAATTCTGGTTGGTCCTCT-3'), type II collagen (COL2A1) (chondrogenic marker) (forward 5'-GGACTTTTCTCCCCTCTCT-3'; reverse 5'-GACCCGAAGGTCTTACAGGA-3'), type I collagen (COL1A1) (osteogenic marker) (forward 5'-ACGTCCTGGTGAAGTTGGTC-3'; reverse 5'-ACCAGGGAAGCCTCTCTCTC-3'), type X collagen (COL10A1) (marker of hypertrophy) (forward 5'-CCCTCTTGTTAGTGCCAACC-3'; reverse 5'-AGATTCCAGTCCTTGGGTCA-3'), alkaline phosphatase (ALP) (osteogenic marker) (forward 5'-TGGAGCTTCAGAAGCTCAACACCA-3'; reverse 5'-ATCTCGTTGTCTGAGTACCAGTCC-3'), matrix metalloproteinase 13 (MMP13) (marker of terminal differentiation) (forward 5'-AATTTTCACTTTTGGCAATGA-3'; reverse 5'-CAAATAATTTATGAAAAAGGGATGC-3'), osteopontin (OP) (osteogenic marker) (forward 5'-ACGCCGACCAAGGAAAACTC-3'; reverse 5'-GTCCATAAACCACACTATCACCTCG-3'), runt-related transcription factor 2 (RUNX2) (osteogenic marker) (forward 5'-GCAGTTCCCAAGCATTTCAT-3'; reverse 5'-CACTCTGGCTTTGGGAAGAG-3'), &#946;-catenin (mediator of the Wnt signaling pathway for osteoblast lineage differentiation) (forward 5'-CAAGTGGGTGGTATAGAGG-3'; reverse 5'-GCGGGACAAAGGGCAAGA-3'), parathyroid hormone-related protein (PTHrP) (hypertrophy-associated gene) (forward 5'-CGACGACACACGCACTTGAAAC-3'; reverse 5'-CGACGCTCCACTGCTGAACC-3'), lipoprotein lipase (LPL) (adipogenic marker) (forward 5'-GAGATTTCTCTGTATGGCACC-3'; reverse 5'-CTGCAAATGAGACACTTTCTC-3'), peroxisome proliferator-activated receptor gamma 2 (PPARG2) (adipogenic marker) (forward 5'-GCTGTTATGGGTGAAACTCTG-3'; reverse 5'-ATAAGGTGGAGATGCAGGCTC-3'), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (housekeeping gene and internal control) (forward 5'-GAAGGTGAAGGTCGGAGTC-3'; reverse 5'-GAAGATGGTGATGGGATTTC-3') (all 150 n<it>M </it>final concentration) <abbrgrp><abbr bid="B13">13</abbr><abbr bid="B15">15</abbr><abbr bid="B16">16</abbr><abbr bid="B46">46</abbr><abbr bid="B47">47</abbr><abbr bid="B48">48</abbr><abbr bid="B49">49</abbr></abbrgrp>. Control conditions included reactions using water and non-reverse-transcribed mRNA. Specificity of the products was confirmed by melting curve analysis and agarose gel electrophoresis. The threshold cycle (Ct) value for each gene of interest was measured for each amplified sample by using the MxPro QPCR software (Stratagene), and values were normalized to GAPDH expression by using the 2<sup>-&#916;&#916;Ct </sup>method, as previously described <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>.</p>
         </sec>
         <sec>
            <st>
               <p>Statistical analysis</p>
            </st>
            <p>Data are expressed as mean &#177; standard deviation (SD) of separate experiments. Each treatment condition was performed in triplicate in three independent experiments for each patient. Data were obtained by two individuals that were blinded with respect to the treatment groups. The <it>t </it>test and the Mann-Whitney Rank Sum Test were used where appropriate. Any <it>P </it>value of less than 0.05 was considered statistically significant.</p>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <sec>
            <st>
               <p>Efficient and sustained <it>SOX9 </it>overexpression in monolayer cultures of undifferentiated human mesenchymal stem cells via rAAV-mediated gene transfer</p>
            </st>
            <p>Human adult mesenchymal stem cells (hMSCs) were first transduced with the candidate rAAV-FLAG-h<it>SOX9 </it>vector in undifferentiated monolayer cultures compared with control treatments (reporter rAAV-<it>lacZ </it>gene vector application or a condition lacking vector administration) to examine the ability of rAAV to mediate overexpression of the transcription factor over time in these cells <it>in vitro </it>at an undifferentiated stage. Sustained, intense immunoreactivity to the FLAG tag and SOX9 was detected only in cells transduced with rAAV-FLAG-h<it>SOX9 </it>compared with control applications <abbrgrp><abbr bid="B24">24</abbr></abbrgrp> after 5 days (not shown) and for up to 21 days (Figure <figr fid="F1">1a</figr>). Transduction efficiencies ranged between 70% and 82% (X-Gal staining, not shown), in good agreement with previous observations using this class of vectors <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>.</p>
            <fig id="F1">
               <title>
                  <p>Figure 1</p>
               </title>
               <caption>
                  <p>Detection of rAAV-mediated transgene expression in undifferentiated monolayer and chondrogenically differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <text>
                  <p><b>Detection of rAAV-mediated transgene expression in undifferentiated monolayer and chondrogenically differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</b>. Cells were transduced with rAAV-<it>lacZ </it>or rAAV-FLAG-h<it>SOX9 </it><b>(a) </b>in monolayer culture (40 &#956;l each vector) or <b>(b) </b>in aggregate cultures (100 &#956;l each vector), as described in Materials and methods, or left untreated, and processed to monitor transgene expression 21 days after vector application by analyzing the immunoreactivity to the FLAG tag or to SOX9. (<b>a</b>) Anti-FLAG at magnification &#215;20 and anti-SOX9 at magnification &#215;4; (<b>b</b>) magnification &#215;4.</p>
               </text>
               <graphic file="scrt113-1" hint_layout="double"/>
            </fig>
         </sec>
         <sec>
            <st>
               <p>Effects of rAAV-FLAG-h<it>SOX9 </it>treatment on the proliferation and viability of undifferentiated hMSCs</p>
            </st>
            <p>The candidate rAAV-FLAG-h<it>SOX9 </it>vector was next applied over time to undifferentiated monolayer cultures of hMSCs to investigate potential undesirable effects of the gene-transfer method and of the candidate factor on cell proliferation and viability compared with control conditions (rAAV-<it>lacZ </it>transduction and absence of vector treatment). Application of rAAV-FLAG-h<it>SOX9 </it>did not significantly modify the cell numbers, viability, proliferation rates (WST-1 assay), or DNA contents of the cultures compared with control treatments (<it>P </it>&#8805; 0.106) (Table <tblr tid="T1">1</tblr>). Over time, these parameters decreased in all the conditions tested (<it>P </it>&#8804; 0.029), as previously observed by using similar controls in experimental settings <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>.</p>
            <tbl id="T1" hint_layout="double">
               <title>
                  <p>Table 1</p>
               </title>
               <caption>
                  <p>Analyses in undifferentiated monolayer cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <tblbdy cols="7">
                  <r>
                     <c ca="left">
                        <p><b>Assay</b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>No vector</b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>rAAV-<it>lacZ</it></b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>rAAV-FLAG-h<it>SOX9</it></b></p>
                     </c>
                  </r>
                  <r>
                     <c>
                        <p/>
                     </c>
                     <c cspan="6">
                        <hr/>
                     </c>
                  </r>
                  <r>
                     <c>
                        <p/>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                  </r>
                  <r>
                     <c cspan="7">
                        <hr/>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Viable cells</p>
                     </c>
                     <c ca="left">
                        <p>1,225 (50)</p>
                     </c>
                     <c ca="left">
                        <p>855 (25)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>1,250 (45)</p>
                     </c>
                     <c ca="left">
                        <p>835 (20)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>1,220 (40)</p>
                     </c>
                     <c ca="left">
                        <p>840(25)<sup>a</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Viability (%)</p>
                     </c>
                     <c ca="left">
                        <p>92 (2)</p>
                     </c>
                     <c ca="left">
                        <p>53 (2)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>91 (3)</p>
                     </c>
                     <c ca="left">
                        <p>51 (2)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>93 (3)</p>
                     </c>
                     <c ca="left">
                        <p>53 (2)<sup>a</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>WST -1 (OD<sup>450 nm</sup>)</p>
                     </c>
                     <c ca="left">
                        <p>0.34 (0.02)</p>
                     </c>
                     <c ca="left">
                        <p>0.27 (0.02)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.32 (0.03)</p>
                     </c>
                     <c ca="left">
                        <p>0.24 (0.01)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.35 (0.03)</p>
                     </c>
                     <c ca="left">
                        <p>0.26 (0.02)<sup>a</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>DNA (ng/mg total proteins)</p>
                     </c>
                     <c ca="left">
                        <p>0.19 (0.02)</p>
                     </c>
                     <c ca="left">
                        <p>0.11 (0.01)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.21 (0.02)</p>
                     </c>
                     <c ca="left">
                        <p>0.12 (0.01)<sup>a</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.18 (0.01)</p>
                     </c>
                     <c ca="left">
                        <p>0.14 (0.01)<sup>a</sup></p>
                     </c>
                  </r>
               </tblbdy>
               <tblfn>
                  <p>Values are given as mean (SD) by using a vector dose of 40 &#956;l. <sup>a</sup>Statistically significant compared with earlier time point.</p>
               </tblfn>
            </tbl>
         </sec>
         <sec>
            <st>
               <p>Efficient and sustained <it>SOX9 </it>overexpression in chondrogenically differentiated cultures of hMSCs via rAAV</p>
            </st>
            <p>hMSCs were next transduced in chondrogenically differentiated (aggregate) cultures over time with rAAV-FLAG-h<it>SOX9 </it>compared with control treatments (rAAV-<it>lacZ </it>or absence of vector application) to determine the ability of rAAV to mediate <it>SOX9 </it>overexpression in a three-dimensional environment adequate for chondrogenic differentiation. In good agreement with the findings in monolayer culture, prolonged FLAG tag expression was seen only in aggregates treated with rAAV-FLAG-h<it>SOX9 </it>after 5 days and for up to 21 days, again reaching high transduction efficiencies (80% to 85%) <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>, whereas SOX9 immunoreactivity was noted in all types of aggregates as a result of the chondrogenic induction <abbrgrp><abbr bid="B50">50</abbr></abbrgrp>, although specific staining was more intense (about ninefold) when the <it>SOX9 </it>vector was provided (Figure <figr fid="F1">1b</figr>). No apparent difference in SOX9 immunostaining was noted between control conditions, suggesting that gene transfer via rAAV did not alter the potency of hMSCs, consistent with previous observations with this class of vector <abbrgrp><abbr bid="B8">8</abbr><abbr bid="B16">16</abbr><abbr bid="B34">34</abbr></abbrgrp>.</p>
         </sec>
         <sec>
            <st>
               <p>Effects of rAAV-FLAG-h<it>SOX9 </it>treatment on the proliferative, metabolic, and chondrogenic properties of induced hMSCs</p>
            </st>
            <p>rAAV-FLAG-h<it>SOX9 </it>was then used to evaluate the effects of the transcription factor via rAAV administration on the proliferative, biosynthetic, and differentiative activities of hMSCs in conditions of chondrogenic induction (aggregate cultures) over time compared with control conditions (rAAV-<it>lacZ </it>transduction and absence of vector treatment).</p>
            <p>Application of rAAV-FLAG-h<it>SOX9 </it>significantly increased the diameters of the aggregates over time and compared with control conditions (up to 1.6-fold; always <it>P </it>&#8804; 0.001) (Figure <figr fid="F2">2</figr> and Table <tblr tid="T2">2</tblr>), in which instead significant decreases were noted during the course of the evaluation (up to 1.03-fold; always <it>P </it>&#8804; 0.001) without difference at similar time points (<it>P </it>&#8805; 0.125), as previously reported <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. Interestingly, this effect of <it>SOX9 </it>treatment was not accompanied by increases in the cell densities (H&amp;E staining), proliferation rates (WST-1 assay), or DNA contents in the aggregates (Figure <figr fid="F2">2</figr> and Table <tblr tid="T2">2</tblr>), as no difference was found between <it>SOX9</it>-, rAAV-<it>lacZ</it>-treated, and untreated aggregates at similar time points for these parameters (<it>P </it>&#8805; 0.389) that decreased over time in all types of aggregates (up to 2.2-fold; <it>P </it>&#8804; 0.002), consistent with the findings in monolayer culture and with previous observations <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>.</p>
            <fig id="F2">
               <title>
                  <p>Figure 2</p>
               </title>
               <caption>
                  <p>Histologic analyses in chondrogenically differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <text>
                  <p><b>Histologic analyses in chondrogenically differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</b>. Aggregate cultures were prepared and transduced with rAAV-<it>lacZ </it>or rAAV-FLAG-h<it>SOX9</it>, as described in Figure 1, or left untreated, and processed on day 21 for histologic staining with H&amp;E, toluidine blue, and alizarin red, as described in Materials and methods. All at magnification &#215;4.</p>
               </text>
               <graphic file="scrt113-2" hint_layout="single"/>
            </fig>
            <tbl id="T2" hint_layout="double">
               <title>
                  <p>Table 2</p>
               </title>
               <caption>
                  <p>Analyses in chondrogenically differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <tblbdy cols="7">
                  <r>
                     <c ca="left">
                        <p><b>Assay</b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>No vector</b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>rAAV-<it>lacZ</it></b></p>
                     </c>
                     <c cspan="2" ca="left">
                        <p><b>rAAV-FLAG-h<it>SOX9</it></b></p>
                     </c>
                  </r>
                  <r>
                     <c>
                        <p/>
                     </c>
                     <c cspan="6">
                        <hr/>
                     </c>
                  </r>
                  <r>
                     <c>
                        <p/>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 7</b></p>
                     </c>
                     <c ca="left">
                        <p><b>Day 21</b></p>
                     </c>
                  </r>
                  <r>
                     <c cspan="7">
                        <hr/>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Diameter (&#956;m)</p>
                     </c>
                     <c ca="left">
                        <p>632 (6)</p>
                     </c>
                     <c ca="left">
                        <p>618 (4)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>630 (2)</p>
                     </c>
                     <c ca="left">
                        <p>614 (3)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>729 (4)<sup>a, b</sup></p>
                     </c>
                     <c ca="left">
                        <p>982 (5)<sup>a, b, c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Cell density (cells/mm<sup>2</sup>)</p>
                     </c>
                     <c ca="left">
                        <p>433 (7)</p>
                     </c>
                     <c ca="left">
                        <p>424 (2)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>438 (4)</p>
                     </c>
                     <c ca="left">
                        <p>426 (1)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>437 (4)</p>
                     </c>
                     <c ca="left">
                        <p>425 (5)<sup>c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>WST-1 (OD<sup>450 nm</sup>)</p>
                     </c>
                     <c ca="left">
                        <p>1.33 (0.17)</p>
                     </c>
                     <c ca="left">
                        <p>0.62 (0.12)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>1.29 (0.21)</p>
                     </c>
                     <c ca="left">
                        <p>0.67 (0.12)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>1.31 (0.15)</p>
                     </c>
                     <c ca="left">
                        <p>0.65 (0.14)<sup>c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>DNA (ng/mg total proteins)</p>
                     </c>
                     <c ca="left">
                        <p>0.92 (0.02)</p>
                     </c>
                     <c ca="left">
                        <p>0.87 (0.02)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.90 (0.01)</p>
                     </c>
                     <c ca="left">
                        <p>0.86 (0.01)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.92 (0.01)</p>
                     </c>
                     <c ca="left">
                        <p>0.88 (0.02)<sup>c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Toluidine blue intensity (pixels)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>167 (4)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>169 (5)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>914 (7)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Proteoglycans (ng/mg total proteins)</p>
                     </c>
                     <c ca="left">
                        <p>0.61 (0.02)</p>
                     </c>
                     <c ca="left">
                        <p>0.79 (0.04)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.59 (0.03)</p>
                     </c>
                     <c ca="left">
                        <p>0.80 (0.02)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>3.37 (0.06)<sup>a, b</sup></p>
                     </c>
                     <c ca="left">
                        <p>4.68 (0.07)<sup>a, b, c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Proteoglycans/DNA (ng/ng)</p>
                     </c>
                     <c ca="left">
                        <p>0.67 (0.04)</p>
                     </c>
                     <c ca="left">
                        <p>0.91 (0.03)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>0.66 (0.03)</p>
                     </c>
                     <c ca="left">
                        <p>0.93 (0.02)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>3.67 (0.04)<sup>a, b</sup></p>
                     </c>
                     <c ca="left">
                        <p>5.32 (0.08)<sup>a, b, c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Type II collagen intensity (%)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>51 (3)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>49 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>85 (3)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Type II collagen (pg/mg total proteins)</p>
                     </c>
                     <c ca="left">
                        <p>13 (2)</p>
                     </c>
                     <c ca="left">
                        <p>18 (3)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>14 (2)</p>
                     </c>
                     <c ca="left">
                        <p>19 (3)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>75 (4)<sup>a, b</sup></p>
                     </c>
                     <c ca="left">
                        <p>112 (3)<sup>a, b, c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Type II collagen/DNA (pg/ng)</p>
                     </c>
                     <c ca="left">
                        <p>14 (2)</p>
                     </c>
                     <c ca="left">
                        <p>21 (2)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>15 (1)</p>
                     </c>
                     <c ca="left">
                        <p>22 (3)<sup>c</sup></p>
                     </c>
                     <c ca="left">
                        <p>81 (4)<sup>a, b</sup></p>
                     </c>
                     <c ca="left">
                        <p>127 (8)<sup>a, b, c</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Type I collagen intensity (%)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>44 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>42 (4)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>6 (2)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Type X collagen intensity (%)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>45 (3)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>46 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>8 (2)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>Alizarin red intensity (pixels)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>57 (3)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>56 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>5 (2)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>ALP activity (pg/mg total proteins)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>57 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>55 (1)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>25 (1)<sup>a, b</sup></p>
                     </c>
                  </r>
                  <r>
                     <c ca="left">
                        <p>ALP/DNA (pg/ng)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>66 (2)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>64 (3)</p>
                     </c>
                     <c ca="left">
                        <p>ND</p>
                     </c>
                     <c ca="left">
                        <p>28 (1)<sup>a, b</sup></p>
                     </c>
                  </r>
               </tblbdy>
               <tblfn>
                  <p>Values are given as mean (SD) with a vector dose of 100 &#956;l. ALP, alkaline phosphatase; ND, not done. Statistically significant compared with <sup>a</sup>condition without vector treatment, <sup>b</sup>rAAV-<it>lacZ</it>, and <sup>c</sup>earlier time point.</p>
               </tblfn>
            </tbl>
            <p>Remarkably, when the aggregates were processed to monitor the differentiative and metabolic activities of hMSCs, successful chondrogenic differentiation was noted in all types of aggregates, as evidenced by toluidine blue staining and type II collagen deposition (Figures <figr fid="F2">2</figr> and <figr fid="F3">3a</figr>), yet significant increases were noted in the presence of the <it>SOX9 </it>vector for the intensities of toluidine blue staining, the proteoglycan contents (before and after normalization to the DNA contents), and the intensities of type II collagen immunostaining and contents (before and after normalization) compared with control conditions (Figures <figr fid="F2">2</figr> and <figr fid="F3">3a</figr> and Table <tblr tid="T2">2</tblr>) (up to 6.2-fold increase; always <it>P </it>&#8804; 0.001). Notably, the proteoglycan and type II collagen contents significantly increased over time in all types of aggregates (up to 1.6-fold; always <it>P </it>&#8804; 0.001). Also interestingly, no difference was seen between the rAAV-<it>lacZ</it>-treated and untreated aggregates for these parameters at similar time points (<it>P </it>&#8805; 0.439) <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. In marked contrast, application of the <it>SOX9 </it>vector compared with control conditions caused a significant reduction in the intensities of immunostaining for type I and type X collagen, in those of alizarin red staining (up to 9.5-fold; always <it>P </it>&#8804; 0.001), and in the ALP activities (before and after normalization) (up to 2.4-fold; always <it>P </it>&#8804; 0.001) (Figures <figr fid="F2">2</figr> and <figr fid="F3">3a</figr> and Table <tblr tid="T2">2</tblr>). Also interestingly, no difference occurred between rAAV-<it>lacZ</it>-treated and untreated aggregates for any of these parameters when comparing similar time points (<it>P </it>&#8805; 0.570) <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. In contrast with the findings for type II collagen, the type I and type X collagen contents could not be estimated with ELISA, as the values were always below the levels of detection of the assays.</p>
            <fig id="F3">
               <title>
                  <p>Figure 3</p>
               </title>
               <caption>
                  <p>Expression analyses in differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <text>
                  <p><b>Expression analyses in differentiated aggregate cultures of human mesenchymal stem cells (hMSCs)</b>. Aggregate cultures were prepared and transduced with rAAV-<it>lacZ </it>or rAAV-FLAG-h<it>SOX9</it>, as described in Figure 1, or left untreated, and processed on day 21 for <b>(a) </b>immunodetection of type II, type I, and type X collagen (all at magnification &#215;4), and <b>(b) </b>gene-expression analysis by real-time RT-PCR amplification after total cellular RNA extraction and cDNA synthesis, as described in Materials and methods. The genes analyzed included the transcription factor <it>SOX9</it>, and types II, I, and X collagen (COL2A1, COL1A1, COL10A1), alkaline phosphatase (ALP), matrix metalloproteinase 13 (MMP13), osteopontin (OP), the transcription factor RUNX2, &#946;-catenin, parathyroid hormone-related protein (PTHrP), lipoprotein lipase (LPL), and the peroxisome proliferator-activated receptor gamma 2 (PPARG2), with GAPDH serving as a housekeeping gene and internal control (primers are listed in Materials and methods). Ct values were obtained for each target and GAPDH as a control for normalization, and fold inductions (relative to untreated aggregates) were measured by using the 2<sup>-&#916;&#916;Ct </sup>method. Statistically significant compared with (a) condition without vector treatment or (b) rAAV-<it>lacZ</it>.</p>
               </text>
               <graphic file="scrt113-3" hint_layout="single"/>
            </fig>
            <p>The findings related to the biochemical, histologic, and immunohistochemical analyses were corroborated by data from a real-time RT-PCR analysis (Figure <figr fid="F3">3b</figr>). Chondrogenic differentiation of hMSCs was observed in all types of aggregates after 21 days, as seen by detection of <it>SOX9 </it>and type II collagen expression, yet significant differences were noted between <it>SOX9 </it>and control conditions (rAAV-<it>lacZ </it>or no vector treatment) (up to 13-fold higher <it>SOX9 </it>expression levels and up to 4.7-fold higher COL2A1 expression levels in the presence of rAAV-FLAG-h<it>SOX9</it>; always <it>P </it>&#8804; 0.001). Real-time RT-PCR analysis also confirmed the decreased profiles of type I, type X collagen, and ALP when overexpressing <it>SOX9 </it>compared with control treatments (up to 3.3-, 2.5-, and 1.3-fold, respectively; always <it>P </it>&#8804; 0.001). Strikingly, the analysis further revealed opposing effects of <it>SOX9 </it>treatment on the expression of MMP13 (up to 2.2-fold), OP (up to 33.3-fold), RUNX2 (up to 4.8-fold), &#946;-catenin (up to 1.2-fold), LPL (up to 33.3-fold), and PPARG2 (up to 14.3-fold) (always <it>P </it>&#8804; 0.001), while showing activating effects on PTHrP (up to 2.4-fold; <it>P </it>&#8804; 0.001) compared with control conditions. Again as previously reported, no difference was observed between rAAV-<it>lacZ</it>-treated and untreated aggregates for any of the markers analyzed here (<it>P </it>&#8805; 0.417) <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>.</p>
         </sec>
         <sec>
            <st>
               <p>Effects of rAAV-FLAG-h<it>SOX9 </it>treatment on the osteogenic differentiation potential of hMSCs</p>
            </st>
            <p>The candidate <it>SOX9 </it>vector was next provided to osteogenically differentiated hMSCs over time to estimate further the effects of the transcription factor via rAAV application on the potential for osteogenic differentiation of the cells compared with control conditions (rAAV-<it>lacZ </it>transduction and absence of vector treatment).</p>
            <p>Successful differentiation was noted in all types of induced cultures, as evidenced by ALP staining (Figure <figr fid="F4">4a</figr>). Nevertheless, application of rAAV-FLAG-h<it>SOX9 </it>significantly decreased the percentage of stained areas after 21 days compared with control conditions (42% &#177; 2% versus 83% &#177; 2% or 84% &#177; 3% with rAAV-<it>lacZ </it>or without vector, respectively; that is, an up to twofold decrease; always <it>P </it>&#8804; 0.001). This observation was corroborated when estimating the ALP activities of the cultures (5.8 &#177; 0.4 nmol/mg total proteins with rAAV-FLAG-h<it>SOX9 </it>versus 42.4 &#177; 2.3 or 39.2 &#177; 1.6 nmol/mg total proteins with rAAV-<it>lacZ </it>or without vector (that is, an up to 7.3-fold decrease; always <it>P </it>&#8804; 0.001) and with real-time RT-PCR analysis (up to 25-fold decrease in ALP expression; <it>P </it>&#8804; 0.001) (Figure <figr fid="F4">4b</figr>). Treatment with <it>SOX9 </it>also decreased the expression levels of type I collagen, OP, and RUNX2 compared with control transductions (up to 100-fold; <it>P </it>&#8804; 0.001) (Figure <figr fid="F4">4b</figr>). Once again, no difference was noted between rAAV-<it>lacZ</it>-treated and untreated cultures for any of the markers analyzed here (<it>P </it>&#8805; 0.570).</p>
            <fig id="F4">
               <title>
                  <p>Figure 4</p>
               </title>
               <caption>
                  <p>Analyses in osteogenically and adipogenically differentiated cultures of human mesenchymal stem cells (hMSCs)</p>
               </caption>
               <text>
                  <p><b>Analyses in osteogenically and adipogenically differentiated cultures of human mesenchymal stem cells (hMSCs)</b>. Cells in monolayer cultures were transduced with rAAV-<it>lacZ </it>or rAAV-FLAG-h<it>SOX9 </it>(100 &#956;l each vector) or left untreated and induced toward osteogenic or adipogenic differentiation, as described in Materials and methods. Cultures were processed on day 21 for <b>(a) </b>ALP staining (osteogenesis; magnification &#215;4) and Oil Red O staining (adipogenesis; magnification &#215;10) and <b>(b) </b>and <b>(c) </b>gene-expression analysis with real-time RT-PCR amplification, as described in Figure 3. The genes analyzed included <it>ALP, COL1A1, OP</it>, and <it>RUNX2 </it>for osteogenically differentiated cultures (b) and <it>LPL </it>and <it>PPARG2 </it>for adipogenically differentiated cultures (c), with GAPDH serving as a housekeeping gene and internal control in both cases. Ct values were obtained for each target and GAPDH as a control for normalization, and fold inductions (relative to untreated cultures) were measured by using the 2<sup>-&#916;&#916;Ct </sup>method. Statistically significant compared with (a) condition without vector treatment or (b) rAAV-<it>lacZ</it>.</p>
               </text>
               <graphic file="scrt113-4" hint_layout="single"/>
            </fig>
         </sec>
         <sec>
            <st>
               <p>Effects of rAAV-FLAG-h<it>SOX9 </it>treatment on the adipogenic differentiation potential of hMSCs</p>
            </st>
            <p>Finally, the candidate <it>SOX9 </it>vector was provided to adipogenically differentiated hMSCs over time to validate further the effects of the transcription factor through rAAV application on the potential for adipogenic differentiation of the cells compared with control conditions (rAAV-<it>lacZ </it>transduction and absence of vector treatment).</p>
            <p>Successful differentiation was achieved in all types of induced cultures, as seen by the accumulation of lipid droplets after staining with Oil Red O (Figure <figr fid="F4">4a</figr>). However, <it>SOX9 </it>gene transfer significantly decreased the percentage of stained areas after 21 days compared with control conditions (36% &#177; 2% versus 53% &#177; 2% or 51% &#177; 3%, that is, an up to 1.5-fold decrease; always <it>P </it>&#8804; 0.001). This finding was substantiated by real-time PCR expression analysis of LPL and PPARG2, showing significantly decreased levels in the presence of rAAV-FLAG-h<it>SOX9 </it>compared with control treatments (up to 7.7-fold; <it>P </it>&#8804; 0.001) (Figure <figr fid="F4">4c</figr>). Again, no difference was noted between rAAV-<it>lacZ</it>-treated and untreated cultures for any of the markers tested (<it>P </it>&#8805; 0.389).</p>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Discussion</p>
         </st>
         <p>Transplantation of progenitor cells like mesenchymal stem cells (MSCs) from the bone marrow, with an innate potential for chondrogenic differentiation, is a promising strategy to treat articular cartilage defects in patients <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>. Yet, the use of MSCs in such settings is still restrained by the low percentage of cells that enter appropriate chondrocyte lineage-differentiation pathways to produce a reparative tissue of proper quality. It is well known that MSC-derived cells tend to undergo premature terminal differentiation, hypertrophy, and ossification <abbrgrp><abbr bid="B4">4</abbr><abbr bid="B5">5</abbr></abbrgrp>. Such limitations might be overcome by directing the cells toward an adequate phenotype by application and stable expression of candidate genes capable of controlling chondrocyte differentiation. Among the potentially beneficial agents, the transcription factor SOX9 is a strong candidate to adjust chondrogenesis, as a key regulator of chondrocyte differentiation and cartilage formation <abbrgrp><abbr bid="B22">22</abbr></abbrgrp> that can delay hypertrophic maturation at certain stages of differentiation <abbrgrp><abbr bid="B23">23</abbr><abbr bid="B24">24</abbr><abbr bid="B25">25</abbr><abbr bid="B26">26</abbr><abbr bid="B27">27</abbr></abbrgrp>. Instead of using classic nonviral <abbrgrp><abbr bid="B26">26</abbr><abbr bid="B30">30</abbr></abbrgrp>, adeno-, retro-, and lentiviral vectors <abbrgrp><abbr bid="B24">24</abbr><abbr bid="B31">31</abbr><abbr bid="B32">32</abbr><abbr bid="B33">33</abbr></abbrgrp>, we focused on rAAV systems that advantageously genetically modify hMSCs at very high efficiencies and for extended periods without affecting their potential for differentiation <abbrgrp><abbr bid="B8">8</abbr><abbr bid="B16">16</abbr><abbr bid="B34">34</abbr></abbrgrp>. This finding was confirmed here when applying the rAAV-FLAG-h<it>SOX9 </it>vector to undifferentiated monolayer and chondrogenically differentiated hMSC cultures (70% to 85% transduction efficiencies for up to 21 days, with about a ninefold difference in <it>SOX9 </it>expression levels compared with control treatments that showed a similar evolution for all parameters in the evaluation). Equally important, we further demonstrate that the efficient and sustained <it>SOX9 </it>expression levels achieved here with rAAV were capable of promoting and enhancing chondrogenic differentiation of hMSCs in suitable aggregate cultures, with an increased production of major extracellular matrix components (proteoglycans, type II collagen) compared with control conditions, as already seen in human osteoarthritic chondrocytes <abbrgrp><abbr bid="B43">43</abbr></abbrgrp> and in agreement with the properties of this factor <abbrgrp><abbr bid="B22">22</abbr><abbr bid="B24">24</abbr><abbr bid="B26">26</abbr><abbr bid="B27">27</abbr><abbr bid="B31">31</abbr><abbr bid="B32">32</abbr></abbrgrp>. Interestingly, administration of rAAV <it>SOX9 </it>did not further modify the levels of proliferation and viability of hMSCs in all the systems tested compared with control treatments, as also reported with chondrocytes <abbrgrp><abbr bid="B43">43</abbr></abbrgrp>, and instead, these parameters decreased over the course of the evaluation. It remains to be seen whether too elevated levels of <it>SOX9 </it>expression will not cause toxicity on cells transduced through rAAV <abbrgrp><abbr bid="B51">51</abbr></abbrgrp>. This is, however, consistent with previous observations when expanding similar controls of hMSC transduction <abbrgrp><abbr bid="B16">16</abbr></abbrgrp> and, more important, with findings showing the lack or opposing effects of <it>SOX9 </it>on the proliferation and cell-cycle progression of hMSCs in the adult <abbrgrp><abbr bid="B23">23</abbr><abbr bid="B31">31</abbr><abbr bid="B32">32</abbr></abbrgrp>.</p>
         <p>Strikingly, the present results also indicate that prolonged, elevated rAAV-mediated expression of <it>SOX9 </it>significantly reduced the expression and activities of several markers of hypertrophy and terminal or osteogenic differentiation (type I and type X collagen, ALP, MMP13, OP, matrix mineralization), concordant with previous reports showing contrasting effects of SOX9 on osteogenesis, bone formation, terminal differentiation, and calcification and on the expression of these markers <abbrgrp><abbr bid="B23">23</abbr><abbr bid="B24">24</abbr><abbr bid="B25">25</abbr><abbr bid="B26">26</abbr><abbr bid="B27">27</abbr><abbr bid="B31">31</abbr><abbr bid="B52">52</abbr><abbr bid="B53">53</abbr><abbr bid="B54">54</abbr><abbr bid="B55">55</abbr><abbr bid="B56">56</abbr><abbr bid="B57">57</abbr><abbr bid="B58">58</abbr></abbrgrp>. Remarkably, these effects of <it>SOX9 </it>treatment via rAAV were associated with significant decreases in the levels of RUNX2, a transcription factor essential for bone formation, terminal maturation, and mineralization that stimulates the expression of osteoblast-related genes (<it>COL1A1, COL10A1, ALP, MMP13, OP</it>) <abbrgrp><abbr bid="B53">53</abbr><abbr bid="B55">55</abbr><abbr bid="B56">56</abbr><abbr bid="B58">58</abbr><abbr bid="B59">59</abbr><abbr bid="B60">60</abbr><abbr bid="B61">61</abbr><abbr bid="B62">62</abbr></abbrgrp>, again in good agreement with the effects of SOX9 on RUNX2 expression <abbrgrp><abbr bid="B31">31</abbr><abbr bid="B63">63</abbr><abbr bid="B64">64</abbr></abbrgrp>. Interestingly, Ikeda <it>et al. </it><abbrgrp><abbr bid="B24">24</abbr></abbrgrp> reported that <it>SOX9 </it>gene transfer in hMSCs failed to suppress the expression of such hypertrophic and osteogenic markers. However, it is important to mention that, in this previous study, less efficient adenoviral vectors were used and mediated gene expression for about 5 days, whereas sustained and very high levels of transgene <it>SOX9 </it>expression were detected here for at least 21 days. Of further note, we also observed that application of rAAV-FLAG-h<it>SOX9 </it>led to a decrease in &#946;-catenin expression, a mediator of the Wnt signaling pathway known to stimulate osteoblast lineage differentiation <abbrgrp><abbr bid="B65">65</abbr></abbrgrp>. In addition, we noted that the vector increased the levels of PTHrP, an inhibitor of hypertrophic maturation and calcification that has a significant impact on the regulation of gene expression for COL1A1, COL10A1, ALP, and RUNX2, delays bone formation <abbrgrp><abbr bid="B15">15</abbr><abbr bid="B53">53</abbr><abbr bid="B55">55</abbr><abbr bid="B56">56</abbr><abbr bid="B58">58</abbr><abbr bid="B66">66</abbr><abbr bid="B67">67</abbr><abbr bid="B68">68</abbr><abbr bid="B69">69</abbr><abbr bid="B70">70</abbr><abbr bid="B71">71</abbr><abbr bid="B72">72</abbr></abbrgrp>, and activates SOX9 transcriptional activities <abbrgrp><abbr bid="B67">67</abbr></abbrgrp>. The effects of <it>SOX9 </it>evidenced here on these signaling pathways are consistent with reports showing enhanced &#946;-catenin degradation and PTHrP activation mediated by the cartilage-specific transcription factor <abbrgrp><abbr bid="B23">23</abbr><abbr bid="B52">52</abbr><abbr bid="B73">73</abbr></abbrgrp>.</p>
         <p>Altogether, the data demonstrate that concurrent activation and inhibition of different signaling pathways by rAAV <it>SOX9 </it>gene transfer might permit a significant reduction of osteogenic processes in hMSCs. Still, in the present study, evaluations were not performed beyond day 21, and it remains to be seen whether the <it>SOX9</it>-transduced cells will not undergo hypertrophy and terminal or osteogenic differentiation over time if they lose <it>SOX9 </it>expression <abbrgrp><abbr bid="B28">28</abbr><abbr bid="B29">29</abbr></abbrgrp>, an issue that might have consequences for an adequate treatment of cartilage lesions. Also noteworthy, the candidate treatment here also significantly decreased the expression of adipogenic markers (accumulation of lipid droplets, LPL, and PPARG2 levels), allowing containing the adipogenic differentiation of hMSCs, again in good agreement with previous findings <abbrgrp><abbr bid="B27">27</abbr><abbr bid="B57">57</abbr></abbrgrp>. To our best knowledge, this is the first evidence showing that overexpression of <it>SOX9 </it>via rAAV stimulates hMSC chondrogenic differentiation with an important delay in terminal differentiation and hypertrophy, while affecting osteogenic and adipogenic differentiation over a continuous period. Apart from SOX9, the use of other members of the SOX family (SOX5, SOX6) <abbrgrp><abbr bid="B52">52</abbr><abbr bid="B56">56</abbr><abbr bid="B74">74</abbr></abbrgrp> might be of further benefit to favor chondrogenic versus osteo-/adipogenic differentiation of hMSCs, as proposed by various groups who delivered the SOX trio by more classic, less efficient nonviral or adenoviral vectors <abbrgrp><abbr bid="B24">24</abbr><abbr bid="B30">30</abbr></abbrgrp>. Delivery of additional factors displaying proliferative activities might be also valuable to generate high numbers of hMSCs for transplantation in articular cartilage defects. Among various agents with such effects, IGF-I <abbrgrp><abbr bid="B14">14</abbr></abbrgrp>, FGF-2 <abbrgrp><abbr bid="B16">16</abbr><abbr bid="B17">17</abbr></abbrgrp>, hTERT <abbrgrp><abbr bid="B19">19</abbr><abbr bid="B20">20</abbr></abbrgrp>, or Bcl-xL <abbrgrp><abbr bid="B21">21</abbr></abbrgrp> may be potentially provided along with <it>SOX </it>sequences. Again, rAAV are powerful vectors, as they conveniently permit separate expression of multiple genes at the same time within their targets <abbrgrp><abbr bid="B42">42</abbr></abbrgrp>.</p>
         <p>In addition, it will be important to test further whether transplantation of rAAV <it>SOX9</it>-modified MSCs in articular cartilage defects allows for an effective healing of the lesions <it>in vivo</it>, in association with competent chondrogenic differentiation that avoids premature terminal differentiation as noted <it>in vitro</it>. Interesting findings have been reported by Cao <it>et al. </it><abbrgrp><abbr bid="B31">31</abbr></abbrgrp>, who showed that implantation of MSCs modified to overexpress <it>SOX9 </it>in a polyglycolic acid (PGA) scaffold led to better repair of osteochondral defects in rabbits, although the gene-transfer system used was a relatively low efficiency adenoviral vector compared with rAAV that might prove even more effective because of higher levels and duration of transgene expression. Regarding the value of the present approach for cartilage repair, this strategy with rAAV will have to be translated in rabbit MSCs before transplantation of genetically modified cell platforms within cartilage defects <it>in vivo</it>. Parameters to consider will include the amounts of cells to provide, the potential use of control elements to contain transgene expression (lineage-specific or regulatable promoters), and the selection of the best-suited supportive matrix for cell containment in the lesions. Also, long-term evaluations will be necessary to test the mechanical quality of the repair tissue within the defects, as other cells (periosteum-, perichondrium-, adipose-, muscle-derived stem cells, bone marrow aspirates, tissue grafts, or even chondrocytes) might be applied as engineered platforms <abbrgrp><abbr bid="B75">75</abbr><abbr bid="B76">76</abbr><abbr bid="B77">77</abbr><abbr bid="B78">78</abbr></abbrgrp> compared with direct gene-transfer strategies <abbrgrp><abbr bid="B35">35</abbr><abbr bid="B79">79</abbr><abbr bid="B80">80</abbr></abbrgrp>.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusions</p>
         </st>
         <p>The results of the present study indicate that gene transfer through therapeutic rAAV might be largely beneficial to produce an MSC-derived cell population with a strong potential for proper chondrogenic differentiation, as a means to develop indirect gene- and cell-based approaches to treat articular cartilage defects <it>in vivo</it>.</p>
      </sec>
      <sec>
         <st>
            <p>Abbreviations</p>
         </st>
         <p>ALP: alkaline phosphatase; COL2A1: type II collagen; LPL: lipoprotein lipase; MMP13: matrix metalloproteinase 13; MSCs: mesenchymal stem cells; OP: osteopontin; PPARG2: peroxisome proliferator-activated receptor &#947;2; PTHrP: parathyroid hormone-related protein; rAAV: recombinant adenoassociated virus; RUNX2: runt-related transcription factor 2; SOX9: sex-determining region Y-type high-mobility group box 9.</p>
      </sec>
      <sec>
         <st>
            <p>Competing interests</p>
         </st>
         <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec>
         <st>
            <p>Authors' contributions</p>
         </st>
         <p>JKV, ME, HM, GS, and MC performed the experiments and collected the data. JKV, ME, HM, DK, and MC analyzed the data. MC designed the study and drafted and edited the manuscript. All authors approved the final manuscript.</p>
      </sec>
   </bdy>
   <bm>
      <ack>
         <sec>
            <st>
               <p>Acknowledgements</p>
            </st>
            <p>This research was funded by grants from the German Research Society (<it>Deutsche Forschungsgemeinschaft </it>DFG grants CU 55/1-1, 1-2, and 1-3 of MC and HM) and the German Osteoarthritis Foundation (<it>Deutsche Arthrose-Hilfe </it>DAH of MC, HM, and DK). We thank R. J. Samulski (The Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA), X. Xiao (The Gene Therapy Center, University of Pittsburgh, Pittsburgh, PA, USA), and E. F. Terwilliger (Division of Experimental Medicine, Harvard Institutes of Medicine and Beth Israel Deaconess Medical Center, Boston, MA, USA) for providing genomic AAV-2 plasmid clones and the 293 cell line, and G. Scherer (Institute for Human Genetics and Anthropology, Albert-Ludwig University, Freiburg, Germany) for the human <it>SOX9 </it>cDNA.</p>
         </sec>
      </ack>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Mesenchymal stem cells: clinical applications and biological characterization</p>
            </title>
            <aug>
               <au>
                  <snm>Barry</snm>
                  <fnm>FP</fnm>
               </au>
               <au>
                  <snm>Murphy</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Int J Biochem Cell Biol</source>
            <pubdate>2004</pubdate>
            <volume>36</volume>
            <fpage>568</fpage>
            <lpage>584</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.biocel.2003.11.001</pubid>
                  <pubid idtype="pmpid" link="fulltext">15010324</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>Mesenchymal stem cell therapy for knee osteoarthritis: preliminary report of four patients</p>
            </title>
            <aug>
               <au>
                  <snm>Davatchi</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Abdollahi</snm>
                  <fnm>BS</fnm>
               </au>
               <au>
                  <snm>Mohyeddin</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Shahram</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Nikbin</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Int J Rheum Dis</source>
            <pubdate>2011</pubdate>
            <volume>14</volume>
            <fpage>211</fpage>
            <lpage>215</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1111/j.1756-185X.2011.01599.x</pubid>
                  <pubid idtype="pmpid" link="fulltext">21518322</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months</p>
            </title>
            <aug>
               <au>
                  <snm>Wakitani</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Okabe</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Horibe</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Mitsuoka</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Saito</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Koyama</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Nawata</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Tensho</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Kato</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Uematsu</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Kuroda</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Kurosaka</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Yoshiya</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Hattori</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Ohgushi</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>J Tissue Eng Regen Med</source>
            <pubdate>2011</pubdate>
            <volume>5</volume>
            <fpage>146</fpage>
            <lpage>150</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/term.299</pubid>
                  <pubid idtype="pmpid" link="fulltext">20603892</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B4">
            <title>
               <p>Stem cells and cartilage development: complexities of a simple tissue</p>
            </title>
            <aug>
               <au>
                  <snm>Hollander</snm>
                  <fnm>AP</fnm>
               </au>
               <au>
                  <snm>Dickinson</snm>
                  <fnm>SC</fnm>
               </au>
               <au>
                  <snm>Kafienah</snm>
                  <fnm>W</fnm>
               </au>
            </aug>
            <source>Stem Cells</source>
            <pubdate>2010</pubdate>
            <volume>28</volume>
            <fpage>1992</fpage>
            <lpage>1996</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/stem.534</pubid>
                  <pubid idtype="pmcid">3003945</pubid>
                  <pubid idtype="pmpid" link="fulltext">20882533</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B5">
            <title>
               <p>Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms</p>
            </title>
            <aug>
               <au>
                  <snm>Prockop</snm>
                  <fnm>DJ</fnm>
               </au>
            </aug>
            <source>Mol Ther</source>
            <pubdate>2009</pubdate>
            <volume>17</volume>
            <fpage>939</fpage>
            <lpage>946</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/mt.2009.62</pubid>
                  <pubid idtype="pmcid">2835176</pubid>
                  <pubid idtype="pmpid" link="fulltext">19337235</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B6">
            <title>
               <p>Gene transfer and living release of transforming growth factor-beta3 for cartilage tissue engineering applications</p>
            </title>
            <aug>
               <au>
                  <snm>Hao</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Yao</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Varshney</snm>
                  <fnm>RR</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Prakash</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Li</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>DA</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part C</source>
            <pubdate>2008</pubdate>
            <volume>14</volume>
            <fpage>273</fpage>
            <lpage>280</lpage>
            <xrefbib>
               <pubid idtype="doi">10.1089/ten.tec.2008.0163</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B7">
            <title>
               <p>Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures</p>
            </title>
            <aug>
               <au>
                  <snm>Kawamura</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Chu</snm>
                  <fnm>CR</fnm>
               </au>
               <au>
                  <snm>Sobajima</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Robbins</snm>
                  <fnm>PD</fnm>
               </au>
               <au>
                  <snm>Fu</snm>
                  <fnm>FH</fnm>
               </au>
               <au>
                  <snm>Izzo</snm>
                  <fnm>NJ</fnm>
               </au>
               <au>
                  <snm>Niyibizi</snm>
                  <fnm>C</fnm>
               </au>
            </aug>
            <source>Exp Hematol</source>
            <pubdate>2005</pubdate>
            <volume>33</volume>
            <fpage>865</fpage>
            <lpage>872</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.exphem.2005.05.010</pubid>
                  <pubid idtype="pmcid">1360180</pubid>
                  <pubid idtype="pmpid" link="fulltext">16038778</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B8">
            <title>
               <p>Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair</p>
            </title>
            <aug>
               <au>
                  <snm>Pagnotto</snm>
                  <fnm>MR</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Karpie</snm>
                  <fnm>JC</fnm>
               </au>
               <au>
                  <snm>Ferreti</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Xiao</snm>
                  <fnm>X</fnm>
               </au>
               <au>
                  <snm>Chu</snm>
                  <fnm>CR</fnm>
               </au>
            </aug>
            <source>Gene Ther</source>
            <pubdate>2007</pubdate>
            <volume>14</volume>
            <fpage>804</fpage>
            <lpage>813</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/sj.gt.3302938</pubid>
                  <pubid idtype="pmpid" link="fulltext">17344902</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B9">
            <title>
               <p>Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro</p>
            </title>
            <aug>
               <au>
                  <snm>Palmer</snm>
                  <fnm>GD</fnm>
               </au>
               <au>
                  <snm>Steinert</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Pascher</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Gouze</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Gouze</snm>
                  <fnm>JN</fnm>
               </au>
               <au>
                  <snm>Betz</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Johnstone</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Evans</snm>
                  <fnm>CH</fnm>
               </au>
               <au>
                  <snm>Ghivizzani</snm>
                  <fnm>SC</fnm>
               </au>
            </aug>
            <source>Mol Ther</source>
            <pubdate>2005</pubdate>
            <volume>12</volume>
            <fpage>219</fpage>
            <lpage>228</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.ymthe.2005.03.024</pubid>
                  <pubid idtype="pmpid" link="fulltext">16043093</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B10">
            <title>
               <p>Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer</p>
            </title>
            <aug>
               <au>
                  <snm>Steinert</snm>
                  <fnm>AF</fnm>
               </au>
               <au>
                  <snm>Palmer</snm>
                  <fnm>GD</fnm>
               </au>
               <au>
                  <snm>Pilapil</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Noth</snm>
                  <fnm>U</fnm>
               </au>
               <au>
                  <snm>Evans</snm>
                  <fnm>CH</fnm>
               </au>
               <au>
                  <snm>Ghivizzani</snm>
                  <fnm>SC</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part A</source>
            <pubdate>2009</pubdate>
            <volume>15</volume>
            <fpage>1127</fpage>
            <lpage>1139</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/ten.tea.2007.0252</pubid>
                  <pubid idtype="pmcid">2810414</pubid>
                  <pubid idtype="pmpid" link="fulltext">18826340</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B11">
            <title>
               <p>In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2</p>
            </title>
            <aug>
               <au>
                  <snm>Wang</snm>
                  <fnm>WG</fnm>
               </au>
               <au>
                  <snm>Lou</snm>
                  <fnm>SQ</fnm>
               </au>
               <au>
                  <snm>Ju</snm>
                  <fnm>XD</fnm>
               </au>
               <au>
                  <snm>Xia</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Xia</snm>
                  <fnm>JH</fnm>
               </au>
            </aug>
            <source>Tissue Cell</source>
            <pubdate>2003</pubdate>
            <volume>35</volume>
            <fpage>69</fpage>
            <lpage>77</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0040-8166(02)00106-4</pubid>
                  <pubid idtype="pmpid" link="fulltext">12589731</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B12">
            <title>
               <p>Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells</p>
            </title>
            <aug>
               <au>
                  <snm>Park</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Gelse</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Frank</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>von der Mark</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Aigner</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Schnider</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>J Gene Med</source>
            <pubdate>2006</pubdate>
            <volume>8</volume>
            <fpage>112</fpage>
            <lpage>125</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/jgm.826</pubid>
                  <pubid idtype="pmpid" link="fulltext">16142704</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B13">
            <title>
               <p>Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer</p>
            </title>
            <aug>
               <au>
                  <snm>Steinert</snm>
                  <fnm>AF</fnm>
               </au>
               <au>
                  <snm>Proffen</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Kunz</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Hendrich</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Ghivizzani</snm>
                  <fnm>SC</fnm>
               </au>
               <au>
                  <snm>Noth</snm>
                  <fnm>U</fnm>
               </au>
               <au>
                  <snm>Rethwilm</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Eulert</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Evans</snm>
                  <fnm>CH</fnm>
               </au>
            </aug>
            <source>Arthritis Res Ther</source>
            <pubdate>2009</pubdate>
            <volume>11</volume>
            <fpage>R148</fpage>
            <lpage>R162</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1186/ar2822</pubid>
                  <pubid idtype="pmcid">2787261</pubid>
                  <pubid idtype="pmpid" link="fulltext">19799789</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B14">
            <title>
               <p>Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling</p>
            </title>
            <aug>
               <au>
                  <snm>Longobardi</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>O'Rear</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Aakula</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Johnstone</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Shimer</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Chytil</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Horton</snm>
                  <fnm>WA</fnm>
               </au>
               <au>
                  <snm>Moses</snm>
                  <fnm>HL</fnm>
               </au>
               <au>
                  <snm>Spagnoli</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>J Bone Miner Res</source>
            <pubdate>2006</pubdate>
            <volume>21</volume>
            <fpage>626</fpage>
            <lpage>636</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">16598383</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B15">
            <title>
               <p>Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Weiss</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Hennig</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Bock</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Steck</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Richter</snm>
                  <fnm>W</fnm>
               </au>
            </aug>
            <source>J Cell Physiol</source>
            <pubdate>2010</pubdate>
            <volume>223</volume>
            <fpage>84</fpage>
            <lpage>93</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">20049852</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B16">
            <title>
               <p>Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2</p>
            </title>
            <aug>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Ekici</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Schetting</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part A</source>
            <pubdate>2011</pubdate>
            <volume>17</volume>
            <fpage>1921</fpage>
            <lpage>1933</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/ten.tea.2011.0018</pubid>
                  <pubid idtype="pmpid" link="fulltext">21417714</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B17">
            <title>
               <p>Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Solchaga</snm>
                  <fnm>LA</fnm>
               </au>
               <au>
                  <snm>Penick</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Goldberg</snm>
                  <fnm>VM</fnm>
               </au>
               <au>
                  <snm>Caplan</snm>
                  <fnm>AI</fnm>
               </au>
               <au>
                  <snm>Welter</snm>
                  <fnm>JF</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part A</source>
            <pubdate>2010</pubdate>
            <volume>16</volume>
            <fpage>1009</fpage>
            <lpage>1019</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/ten.tea.2009.0100</pubid>
                  <pubid idtype="pmcid">2862658</pubid>
                  <pubid idtype="pmpid" link="fulltext">19842915</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B18">
            <title>
               <p>Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair</p>
            </title>
            <aug>
               <au>
                  <snm>Liu</snm>
                  <fnm>TM</fnm>
               </au>
               <au>
                  <snm>Guo</snm>
                  <fnm>XM</fnm>
               </au>
               <au>
                  <snm>Tan</snm>
                  <fnm>HS</fnm>
               </au>
               <au>
                  <snm>Hui</snm>
                  <fnm>JH</fnm>
               </au>
               <au>
                  <snm>Lim</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Lee</snm>
                  <fnm>EH</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2011</pubdate>
            <volume>63</volume>
            <fpage>2711</fpage>
            <lpage>2720</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.30430</pubid>
                  <pubid idtype="pmpid" link="fulltext">21547890</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B19">
            <title>
               <p>Stabilization of cellular properties and differentiation multipotential of human mesenchymal stem cells transduced with hTERT gene in a long-term culture</p>
            </title>
            <aug>
               <au>
                  <snm>Huang</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Zheng</snm>
                  <fnm>Q</fnm>
               </au>
               <au>
                  <snm>Sun</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Guo</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Yang</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Chen</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Xu</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Shen</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Pan</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Jin</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>J Cell Biochem</source>
            <pubdate>2008</pubdate>
            <volume>103</volume>
            <fpage>1256</fpage>
            <lpage>1269</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/jcb.21502</pubid>
                  <pubid idtype="pmpid" link="fulltext">18027880</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B20">
            <title>
               <p>Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells</p>
            </title>
            <aug>
               <au>
                  <snm>Simonsen</snm>
                  <fnm>JL</fnm>
               </au>
               <au>
                  <snm>Rosada</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Serakinci</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Justesen</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Stenderup</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Rattan</snm>
                  <fnm>SI</fnm>
               </au>
               <au>
                  <snm>Jensen</snm>
                  <fnm>TG</fnm>
               </au>
               <au>
                  <snm>Kassem</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Nat Biotechnol</source>
            <pubdate>2002</pubdate>
            <volume>20</volume>
            <fpage>592</fpage>
            <lpage>596</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/nbt0602-592</pubid>
                  <pubid idtype="pmpid" link="fulltext">12042863</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B21">
            <title>
               <p>Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model</p>
            </title>
            <aug>
               <au>
                  <snm>Hu</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Ren</snm>
                  <fnm>JL</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>JR</fnm>
               </au>
               <au>
                  <snm>Ma</snm>
                  <fnm>Q</fnm>
               </au>
               <au>
                  <snm>Liu</snm>
                  <fnm>YP</fnm>
               </au>
               <au>
                  <snm>Mao</snm>
                  <fnm>TQ</fnm>
               </au>
            </aug>
            <source>J Tissue Eng Regen Med</source>
            <pubdate>2010</pubdate>
            <volume>4</volume>
            <fpage>105</fpage>
            <lpage>114</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/term.212</pubid>
                  <pubid idtype="pmpid" link="fulltext">19927304</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B22">
            <title>
               <p>Sox9 is required for cartilage formation</p>
            </title>
            <aug>
               <au>
                  <snm>Bi</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Deng</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Behringer</snm>
                  <fnm>RR</fnm>
               </au>
               <au>
                  <snm>de Crombrugghe</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Nat Genet</source>
            <pubdate>1999</pubdate>
            <volume>22</volume>
            <fpage>85</fpage>
            <lpage>89</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/8792</pubid>
                  <pubid idtype="pmpid" link="fulltext">10319868</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B23">
            <title>
               <p>Interactions between Sox9 and beta-catenin control chondrocyte differentiation</p>
            </title>
            <aug>
               <au>
                  <snm>Akiyama</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Lyons</snm>
                  <fnm>JP</fnm>
               </au>
               <au>
                  <snm>Mori-Akiyama</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Yang</snm>
                  <fnm>X</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Deng</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Taketo</snm>
                  <fnm>MM</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Behringer</snm>
                  <fnm>RR</fnm>
               </au>
               <au>
                  <snm>McCrea</snm>
                  <fnm>PD</fnm>
               </au>
               <au>
                  <snm>de Crombrugghe</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Genes Dev</source>
            <pubdate>2004</pubdate>
            <volume>18</volume>
            <fpage>1072</fpage>
            <lpage>1087</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1101/gad.1171104</pubid>
                  <pubid idtype="pmcid">406296</pubid>
                  <pubid idtype="pmpid" link="fulltext">15132997</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B24">
            <title>
               <p>The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage</p>
            </title>
            <aug>
               <au>
                  <snm>Ikeda</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Kamekura</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Mabuchi</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Kou</snm>
                  <fnm>I</fnm>
               </au>
               <au>
                  <snm>Seki</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Takato</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Kawaguchi</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Ikegawa</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Chung</snm>
                  <fnm>UI</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2004</pubdate>
            <volume>50</volume>
            <fpage>3561</fpage>
            <lpage>3573</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.20611</pubid>
                  <pubid idtype="pmpid" link="fulltext">15529345</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B25">
            <title>
               <p>SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression</p>
            </title>
            <aug>
               <au>
                  <snm>Leung</snm>
                  <fnm>VY</fnm>
               </au>
               <au>
                  <snm>Gao</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Leung</snm>
                  <fnm>KK</fnm>
               </au>
               <au>
                  <snm>Melhado</snm>
                  <fnm>IG</fnm>
               </au>
               <au>
                  <snm>Wynn</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Au</snm>
                  <fnm>TY</fnm>
               </au>
               <au>
                  <snm>Dung</snm>
                  <fnm>NW</fnm>
               </au>
               <au>
                  <snm>Lau</snm>
                  <fnm>JY</fnm>
               </au>
               <au>
                  <snm>Mak</snm>
                  <fnm>AC</fnm>
               </au>
               <au>
                  <snm>Chan</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Cheah</snm>
                  <fnm>KS</fnm>
               </au>
            </aug>
            <source>PLoS Genet</source>
            <pubdate>2011</pubdate>
            <volume>7</volume>
            <fpage>e1002356</fpage>
            <lpage>e1002371</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1371/journal.pgen.1002356</pubid>
                  <pubid idtype="pmcid">3207907</pubid>
                  <pubid idtype="pmpid" link="fulltext">22072985</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B26">
            <title>
               <p>Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Tsuchiya</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Kitoh</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Sugiura</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Ishiguro</snm>
                  <fnm>N</fnm>
               </au>
            </aug>
            <source>Biochem Biophys Res Commun</source>
            <pubdate>2003</pubdate>
            <volume>301</volume>
            <fpage>338</fpage>
            <lpage>343</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0006-291X(02)03026-7</pubid>
                  <pubid idtype="pmpid" link="fulltext">12565865</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B27">
            <title>
               <p>Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9</p>
            </title>
            <aug>
               <au>
                  <snm>Wang</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Sul</snm>
                  <fnm>HS</fnm>
               </au>
            </aug>
            <source>Cell Metab</source>
            <pubdate>2009</pubdate>
            <volume>9</volume>
            <fpage>287</fpage>
            <lpage>302</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.cmet.2009.01.013</pubid>
                  <pubid idtype="pmcid">2673480</pubid>
                  <pubid idtype="pmpid" link="fulltext">19254573</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B28">
            <title>
               <p>Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Dy</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Bhattaram</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>Q</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Ballock</snm>
                  <fnm>RT</fnm>
               </au>
               <au>
                  <snm>Lefebvre</snm>
                  <fnm>V</fnm>
               </au>
            </aug>
            <source>Dev Cell</source>
            <pubdate>2012</pubdate>
            <volume>22</volume>
            <fpage>597</fpage>
            <lpage>609</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.devcel.2011.12.024</pubid>
                  <pubid idtype="pmpid" link="fulltext">22421045</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B29">
            <title>
               <p>Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways</p>
            </title>
            <aug>
               <au>
                  <snm>Ikegami</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Akiyama</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Suzuki</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Nakano</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Yoshikawa</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Tsumaki</snm>
                  <fnm>N</fnm>
               </au>
            </aug>
            <source>Development</source>
            <pubdate>2011</pubdate>
            <volume>138</volume>
            <fpage>1507</fpage>
            <lpage>1519</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1242/dev.057802</pubid>
                  <pubid idtype="pmpid" link="fulltext">21367821</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B30">
            <title>
               <p>Electroporation-mediated transfer of SOX trio genes (SOX-5, SOX-6, and SOX-9) to enhance the chondrogenesis of mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Kim</snm>
                  <fnm>HJ</fnm>
               </au>
               <au>
                  <snm>Im</snm>
                  <fnm>GI</fnm>
               </au>
            </aug>
            <source>Stem Cells Dev</source>
            <pubdate>2011</pubdate>
            <volume>20</volume>
            <fpage>2103</fpage>
            <lpage>2114</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/scd.2010.0516</pubid>
                  <pubid idtype="pmpid" link="fulltext">21401405</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B31">
            <title>
               <p>The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Cao</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Yang</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Liu</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Yu</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Li</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Fan</snm>
                  <fnm>Q</fnm>
               </au>
               <au>
                  <snm>Gan</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Tang</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Dai</snm>
                  <fnm>K</fnm>
               </au>
            </aug>
            <source>Biomaterials</source>
            <pubdate>2011</pubdate>
            <volume>32</volume>
            <fpage>3910</fpage>
            <lpage>3920</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.biomaterials.2011.02.014</pubid>
                  <pubid idtype="pmpid" link="fulltext">21377725</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B32">
            <title>
               <p>Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering</p>
            </title>
            <aug>
               <au>
                  <snm>Kupcsik</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Stoddart</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Li</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Benneker</snm>
                  <fnm>LM</fnm>
               </au>
               <au>
                  <snm>Alini</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part A</source>
            <pubdate>2010</pubdate>
            <volume>16</volume>
            <fpage>1845</fpage>
            <lpage>1855</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/ten.tea.2009.0531</pubid>
                  <pubid idtype="pmpid" link="fulltext">20067399</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B33">
            <title>
               <p>Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFbeta-responsive gene</p>
            </title>
            <aug>
               <au>
                  <snm>Li</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Haudenschild</snm>
                  <fnm>DR</fnm>
               </au>
               <au>
                  <snm>Posey</snm>
                  <fnm>KL</fnm>
               </au>
               <au>
                  <snm>Hecht</snm>
                  <fnm>JT</fnm>
               </au>
               <au>
                  <snm>Di Cesare</snm>
                  <fnm>PE</fnm>
               </au>
               <au>
                  <snm>Yik</snm>
                  <fnm>JH</fnm>
               </au>
            </aug>
            <source>Osteoarthritis Cartilage</source>
            <pubdate>2011</pubdate>
            <volume>19</volume>
            <fpage>1246</fpage>
            <lpage>1253</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.joca.2011.07.011</pubid>
                  <pubid idtype="pmpid" link="fulltext">21843649</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B34">
            <title>
               <p>Adeno-associated viral vector transduction of human mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Stender</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Murphy</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>O'Brien</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Stengaard</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Ulrich-Vinther</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Soballe</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Barry</snm>
                  <fnm>F</fnm>
               </au>
            </aug>
            <source>Eur Cell Mater</source>
            <pubdate>2007</pubdate>
            <volume>13</volume>
            <fpage>93</fpage>
            <lpage>99</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">17538898</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B35">
            <title>
               <p>Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2</p>
            </title>
            <aug>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Ma</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Thurn</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Zurakowski</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Menger</snm>
                  <fnm>MD</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Trippel</snm>
                  <fnm>SB</fnm>
               </au>
               <au>
                  <snm>Terwilliger</snm>
                  <fnm>EF</fnm>
               </au>
            </aug>
            <source>Mol Ther</source>
            <pubdate>2005</pubdate>
            <volume>12</volume>
            <fpage>229</fpage>
            <lpage>238</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.ymthe.2005.03.012</pubid>
                  <pubid idtype="pmpid" link="fulltext">16043094</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B36">
            <title>
               <p>Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 study</p>
            </title>
            <aug>
               <au>
                  <snm>Mease</snm>
                  <fnm>PJ</fnm>
               </au>
               <au>
                  <snm>Wei</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Fudman</snm>
                  <fnm>EJ</fnm>
               </au>
               <au>
                  <snm>Kivitz</snm>
                  <fnm>AJ</fnm>
               </au>
               <au>
                  <snm>Schechtman</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Trapp</snm>
                  <fnm>RG</fnm>
               </au>
               <au>
                  <snm>Hobbs</snm>
                  <fnm>KF</fnm>
               </au>
               <au>
                  <snm>Greenwald</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Hou</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Bookbinder</snm>
                  <fnm>SA</fnm>
               </au>
               <au>
                  <snm>Graham</snm>
                  <fnm>GE</fnm>
               </au>
               <au>
                  <snm>Wiesenhutter</snm>
                  <fnm>CW</fnm>
               </au>
               <au>
                  <snm>Willis</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Ruderman</snm>
                  <fnm>EM</fnm>
               </au>
               <au>
                  <snm>Forstot</snm>
                  <fnm>JZ</fnm>
               </au>
               <au>
                  <snm>Maricic</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Dao</snm>
                  <fnm>KH</fnm>
               </au>
               <au>
                  <snm>Pritchard</snm>
                  <fnm>CH</fnm>
               </au>
               <au>
                  <snm>Fiske</snm>
                  <fnm>DN</fnm>
               </au>
               <au>
                  <snm>Burch</snm>
                  <fnm>FX</fnm>
               </au>
               <au>
                  <snm>Prupas</snm>
                  <fnm>HM</fnm>
               </au>
               <au>
                  <snm>Anklesaria</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Heald</snm>
                  <fnm>AE</fnm>
               </au>
            </aug>
            <source>J Rheumatol</source>
            <pubdate>2010</pubdate>
            <volume>37</volume>
            <fpage>692</fpage>
            <lpage>703</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.3899/jrheum.090817</pubid>
                  <pubid idtype="pmpid" link="fulltext">20032102</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B37">
            <title>
               <p>Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components</p>
            </title>
            <aug>
               <au>
                  <snm>Barry</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Boynton</snm>
                  <fnm>RE</fnm>
               </au>
               <au>
                  <snm>Liu</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Murphy</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Exp Cell Res</source>
            <pubdate>2001</pubdate>
            <volume>268</volume>
            <fpage>189</fpage>
            <lpage>200</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1006/excr.2001.5278</pubid>
                  <pubid idtype="pmpid" link="fulltext">11478845</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B38">
            <title>
               <p>Multilineage potential of adult human mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Pittenger</snm>
                  <fnm>MF</fnm>
               </au>
               <au>
                  <snm>Mackay</snm>
                  <fnm>AM</fnm>
               </au>
               <au>
                  <snm>Beck</snm>
                  <fnm>SC</fnm>
               </au>
               <au>
                  <snm>Jaiswal</snm>
                  <fnm>RK</fnm>
               </au>
               <au>
                  <snm>Douglas</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Mosca</snm>
                  <fnm>JD</fnm>
               </au>
               <au>
                  <snm>Moorman</snm>
                  <fnm>MA</fnm>
               </au>
               <au>
                  <snm>Simonetti</snm>
                  <fnm>DW</fnm>
               </au>
               <au>
                  <snm>Craig</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Marshak</snm>
                  <fnm>DR</fnm>
               </au>
            </aug>
            <source>Science</source>
            <pubdate>1999</pubdate>
            <volume>284</volume>
            <fpage>143</fpage>
            <lpage>147</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1126/science.284.5411.143</pubid>
                  <pubid idtype="pmpid" link="fulltext">10102814</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B39">
            <title>
               <p>A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication</p>
            </title>
            <aug>
               <au>
                  <snm>Samulski</snm>
                  <fnm>RJ</fnm>
               </au>
               <au>
                  <snm>Chang</snm>
                  <fnm>LS</fnm>
               </au>
               <au>
                  <snm>Shenk</snm>
                  <fnm>T</fnm>
               </au>
            </aug>
            <source>J Virol</source>
            <pubdate>1987</pubdate>
            <volume>61</volume>
            <fpage>3096</fpage>
            <lpage>3101</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">255885</pubid>
                  <pubid idtype="pmpid" link="fulltext">3041032</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B40">
            <title>
               <p>Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression</p>
            </title>
            <aug>
               <au>
                  <snm>Samulski</snm>
                  <fnm>RJ</fnm>
               </au>
               <au>
                  <snm>Chang</snm>
                  <fnm>LS</fnm>
               </au>
               <au>
                  <snm>Shenk</snm>
                  <fnm>T</fnm>
               </au>
            </aug>
            <source>J Virol</source>
            <pubdate>1989</pubdate>
            <volume>63</volume>
            <fpage>3822</fpage>
            <lpage>3828</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">250975</pubid>
                  <pubid idtype="pmpid" link="fulltext">2547998</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B41">
            <title>
               <p>rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and alpha-SMA expression in human meniscal lesions</p>
            </title>
            <aug>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Schetting</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Terwilliger</snm>
                  <fnm>EF</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Gene Ther</source>
            <pubdate>2009</pubdate>
            <volume>16</volume>
            <fpage>1363</fpage>
            <lpage>1372</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/gt.2009.91</pubid>
                  <pubid idtype="pmpid" link="fulltext">19641531</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B42">
            <title>
               <p>Remodelling of human osteoarthritic cartilage by FGF-2, alone or combined with Sox9 via rAAV gene transfer</p>
            </title>
            <aug>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Terwilliger</snm>
                  <fnm>EF</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>J Cell Mol Med</source>
            <pubdate>2009</pubdate>
            <volume>13</volume>
            <fpage>2476</fpage>
            <lpage>2488</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1111/j.1582-4934.2008.00474.x</pubid>
                  <pubid idtype="pmpid" link="fulltext">18705695</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B43">
            <title>
               <p>Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9</p>
            </title>
            <aug>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Thurn</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Weimer</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Terwilliger</snm>
                  <fnm>EF</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2007</pubdate>
            <volume>56</volume>
            <fpage>158</fpage>
            <lpage>167</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.22299</pubid>
                  <pubid idtype="pmpid" link="fulltext">17195218</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B44">
            <title>
               <p>Benefits of rAAV-mediated IGF-I overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis</p>
            </title>
            <aug>
               <au>
                  <snm>Weimer</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Madry</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Venkatesan</snm>
                  <fnm>JK</fnm>
               </au>
               <au>
                  <snm>Schmitt</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Frisch</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Wezel</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Jung</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Kohn</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Terwilliger</snm>
                  <fnm>EF</fnm>
               </au>
               <au>
                  <snm>Trippel</snm>
                  <fnm>SB</fnm>
               </au>
               <au>
                  <snm>Cucchiarini</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Mol Med</source>
            <pubdate>2012</pubdate>
            <volume>18</volume>
            <fpage>346</fpage>
            <lpage>358</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">3356422</pubid>
                  <pubid idtype="pmpid" link="fulltext">22160392</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B45">
            <title>
               <p>Sex reversal by loss of the C-terminal transactivation domain of human SOX9</p>
            </title>
            <aug>
               <au>
                  <snm>Sudbeck</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Schmitz</snm>
                  <fnm>ML</fnm>
               </au>
               <au>
                  <snm>Baeuerle</snm>
                  <fnm>PA</fnm>
               </au>
               <au>
                  <snm>Scherer</snm>
                  <fnm>G</fnm>
               </au>
            </aug>
            <source>Nat Genet</source>
            <pubdate>1996</pubdate>
            <volume>13</volume>
            <fpage>230</fpage>
            <lpage>232</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/ng0696-230</pubid>
                  <pubid idtype="pmpid" link="fulltext">8640233</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B46">
            <title>
               <p>Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells</p>
            </title>
            <aug>
               <au>
                  <snm>Noth</snm>
                  <fnm>U</fnm>
               </au>
               <au>
                  <snm>Osyczka</snm>
                  <fnm>AM</fnm>
               </au>
               <au>
                  <snm>Tuli</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Hickok</snm>
                  <fnm>NJ</fnm>
               </au>
               <au>
                  <snm>Danielson</snm>
                  <fnm>KG</fnm>
               </au>
               <au>
                  <snm>Tuan</snm>
                  <fnm>RS</fnm>
               </au>
            </aug>
            <source>J Orthop Res</source>
            <pubdate>2002</pubdate>
            <volume>20</volume>
            <fpage>1060</fpage>
            <lpage>1069</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0736-0266(02)00018-9</pubid>
                  <pubid idtype="pmpid" link="fulltext">12382974</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B47">
            <title>
               <p>Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone</p>
            </title>
            <aug>
               <au>
                  <snm>Tuli</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Tuli</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Nandi</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Wang</snm>
                  <fnm>ML</fnm>
               </au>
               <au>
                  <snm>Alexander</snm>
                  <fnm>PG</fnm>
               </au>
               <au>
                  <snm>Haleem-Smith</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Hozack</snm>
                  <fnm>WJ</fnm>
               </au>
               <au>
                  <snm>Manner</snm>
                  <fnm>PA</fnm>
               </au>
               <au>
                  <snm>Danielson</snm>
                  <fnm>KG</fnm>
               </au>
               <au>
                  <snm>Tuan</snm>
                  <fnm>RS</fnm>
               </au>
            </aug>
            <source>Stem Cells</source>
            <pubdate>2003</pubdate>
            <volume>21</volume>
            <fpage>681</fpage>
            <lpage>693</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1634/stemcells.21-6-681</pubid>
                  <pubid idtype="pmpid" link="fulltext">14595128</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B48">
            <title>
               <p>The effects of Wnt inhibitors on the chondrogenesis of human mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Im</snm>
                  <fnm>GI</fnm>
               </au>
               <au>
                  <snm>Quan</snm>
                  <fnm>Z</fnm>
               </au>
            </aug>
            <source>Tissue Eng Part A</source>
            <pubdate>2010</pubdate>
            <volume>16</volume>
            <fpage>2405</fpage>
            <lpage>2413</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1089/ten.tea.2009.0359</pubid>
                  <pubid idtype="pmpid" link="fulltext">19737074</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B49">
            <title>
               <p>Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Mueller</snm>
                  <fnm>MB</fnm>
               </au>
               <au>
                  <snm>Tuan</snm>
                  <fnm>RS</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2008</pubdate>
            <volume>58</volume>
            <fpage>1377</fpage>
            <lpage>1388</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.23370</pubid>
                  <pubid idtype="pmpid" link="fulltext">18438858</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B50">
            <title>
               <p>Cartilage, SOX9 and Notch signals in chondrogenesis</p>
            </title>
            <aug>
               <au>
                  <snm>Hardingham</snm>
                  <fnm>TE</fnm>
               </au>
               <au>
                  <snm>Oldershaw</snm>
                  <fnm>RA</fnm>
               </au>
               <au>
                  <snm>Tew</snm>
                  <fnm>SR</fnm>
               </au>
            </aug>
            <source>J Anat</source>
            <pubdate>2006</pubdate>
            <volume>209</volume>
            <fpage>469</fpage>
            <lpage>480</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1111/j.1469-7580.2006.00630.x</pubid>
                  <pubid idtype="pmcid">2100356</pubid>
                  <pubid idtype="pmpid" link="fulltext">17005019</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B51">
            <title>
               <p>Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9</p>
            </title>
            <aug>
               <au>
                  <snm>Drivdahl</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Haugk</snm>
                  <fnm>KH</fnm>
               </au>
               <au>
                  <snm>Sprenger</snm>
                  <fnm>CC</fnm>
               </au>
               <au>
                  <snm>Nelson</snm>
                  <fnm>PS</fnm>
               </au>
               <au>
                  <snm>Tennant</snm>
                  <fnm>MK</fnm>
               </au>
               <au>
                  <snm>Plymate</snm>
                  <fnm>SR</fnm>
               </au>
            </aug>
            <source>Oncogene</source>
            <pubdate>2004</pubdate>
            <volume>23</volume>
            <fpage>4584</fpage>
            <lpage>4593</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/sj.onc.1207603</pubid>
                  <pubid idtype="pmpid" link="fulltext">15077158</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B52">
            <title>
               <p>Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein</p>
            </title>
            <aug>
               <au>
                  <snm>Amano</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Hata</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Sugita</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Takigawa</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Ono</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Wakabayashi</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Kogo</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Nishimura</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Yoneda</snm>
                  <fnm>T</fnm>
               </au>
            </aug>
            <source>Mol Biol Cell</source>
            <pubdate>2009</pubdate>
            <volume>20</volume>
            <fpage>4541</fpage>
            <lpage>4551</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1091/mbc.E09-03-0227</pubid>
                  <pubid idtype="pmcid">2770942</pubid>
                  <pubid idtype="pmpid" link="fulltext">19759178</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B53">
            <title>
               <p>The control of chondrogenesis</p>
            </title>
            <aug>
               <au>
                  <snm>Goldring</snm>
                  <fnm>MB</fnm>
               </au>
               <au>
                  <snm>Tsuchimochi</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Ijiri</snm>
                  <fnm>K</fnm>
               </au>
            </aug>
            <source>J Cell Biochem</source>
            <pubdate>2006</pubdate>
            <volume>97</volume>
            <fpage>33</fpage>
            <lpage>44</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/jcb.20652</pubid>
                  <pubid idtype="pmpid" link="fulltext">16215986</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B54">
            <title>
               <p>SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification</p>
            </title>
            <aug>
               <au>
                  <snm>Hattori</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Muller</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Gebhard</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Bauer</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Pausch</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Schlund</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Bosl</snm>
                  <fnm>MR</fnm>
               </au>
               <au>
                  <snm>Hess</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Surmann-Schmitt</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>von der Mark</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>de Crombrugghe</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>von der Mark</snm>
                  <fnm>K</fnm>
               </au>
            </aug>
            <source>Development</source>
            <pubdate>2010</pubdate>
            <volume>137</volume>
            <fpage>901</fpage>
            <lpage>911</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1242/dev.045203</pubid>
                  <pubid idtype="pmpid" link="fulltext">20179096</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B55">
            <title>
               <p>PTHrP and skeletal development</p>
            </title>
            <aug>
               <au>
                  <snm>Kronenberg</snm>
                  <fnm>HM</fnm>
               </au>
            </aug>
            <source>Ann N Y Acad Sci</source>
            <pubdate>2006</pubdate>
            <volume>1068</volume>
            <fpage>1</fpage>
            <lpage>13</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1196/annals.1346.002</pubid>
                  <pubid idtype="pmpid" link="fulltext">16831900</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B56">
            <title>
               <p>Transcriptional control of chondrocyte fate and differentiation</p>
            </title>
            <aug>
               <au>
                  <snm>Lefebvre</snm>
                  <fnm>V</fnm>
               </au>
               <au>
                  <snm>Smits</snm>
                  <fnm>P</fnm>
               </au>
            </aug>
            <source>Birth Defects Res C Embryo Today</source>
            <pubdate>2005</pubdate>
            <volume>75</volume>
            <fpage>200</fpage>
            <lpage>221</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/bdrc.20048</pubid>
                  <pubid idtype="pmpid" link="fulltext">16187326</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B57">
            <title>
               <p>Role of preadipocyte factor 1 in adipocyte differentiation</p>
            </title>
            <aug>
               <au>
                  <snm>Wang</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Hudak</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Sul</snm>
                  <fnm>HS</fnm>
               </au>
            </aug>
            <source>Clin Lipidol</source>
            <pubdate>2010</pubdate>
            <volume>5</volume>
            <fpage>109</fpage>
            <lpage>115</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.2217/clp.09.80</pubid>
                  <pubid idtype="pmcid">2856086</pubid>
                  <pubid idtype="pmpid">20414356</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B58">
            <title>
               <p>Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification</p>
            </title>
            <aug>
               <au>
                  <snm>Wuelling</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Vortkamp</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>Pediatr Nephrol</source>
            <pubdate>2010</pubdate>
            <volume>25</volume>
            <fpage>625</fpage>
            <lpage>631</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1007/s00467-009-1368-6</pubid>
                  <pubid idtype="pmpid" link="fulltext">19949815</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B59">
            <title>
               <p>Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors</p>
            </title>
            <aug>
               <au>
                  <snm>Akiyama</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Kim</snm>
                  <fnm>JE</fnm>
               </au>
               <au>
                  <snm>Nakashima</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Balmes</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Iwai</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Deng</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Martin</snm>
                  <fnm>JF</fnm>
               </au>
               <au>
                  <snm>Behringer</snm>
                  <fnm>RR</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>de Crombrugghe</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci USA</source>
            <pubdate>2005</pubdate>
            <volume>102</volume>
            <fpage>14665</fpage>
            <lpage>14670</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1073/pnas.0504750102</pubid>
                  <pubid idtype="pmcid">1239942</pubid>
                  <pubid idtype="pmpid" link="fulltext">16203988</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B60">
            <title>
               <p>Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Drissi</snm>
                  <fnm>MH</fnm>
               </au>
               <au>
                  <snm>Li</snm>
                  <fnm>X</fnm>
               </au>
               <au>
                  <snm>Sheu</snm>
                  <fnm>TJ</fnm>
               </au>
               <au>
                  <snm>Zuscik</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Schwarz</snm>
                  <fnm>EM</fnm>
               </au>
               <au>
                  <snm>Puzas</snm>
                  <fnm>JE</fnm>
               </au>
               <au>
                  <snm>Rosier</snm>
                  <fnm>RN</fnm>
               </au>
               <au>
                  <snm>O'Keefe</snm>
                  <fnm>RJ</fnm>
               </au>
            </aug>
            <source>J Cell Biochem</source>
            <pubdate>2003</pubdate>
            <volume>90</volume>
            <fpage>1287</fpage>
            <lpage>1298</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/jcb.10677</pubid>
                  <pubid idtype="pmpid" link="fulltext">14635200</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B61">
            <title>
               <p>Cbfa1 is a positive regulatory factor in chondrocyte maturation</p>
            </title>
            <aug>
               <au>
                  <snm>Enomoto</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Enomoto-Iwamoto</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Iwamoto</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Nomura</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Himeno</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Kitamura</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Kishimoto</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Komori</snm>
                  <fnm>T</fnm>
               </au>
            </aug>
            <source>J Biol Chem</source>
            <pubdate>2000</pubdate>
            <volume>275</volume>
            <fpage>8695</fpage>
            <lpage>8702</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1074/jbc.275.12.8695</pubid>
                  <pubid idtype="pmpid" link="fulltext">10722711</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B62">
            <title>
               <p>Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation</p>
            </title>
            <aug>
               <au>
                  <snm>Jimenez</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Balbin</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Lopez</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Alvarez</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Komori</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Lopez-Otin</snm>
                  <fnm>C</fnm>
               </au>
            </aug>
            <source>Mol Cell Biol</source>
            <pubdate>1999</pubdate>
            <volume>19</volume>
            <fpage>4431</fpage>
            <lpage>4442</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">104402</pubid>
                  <pubid idtype="pmpid" link="fulltext">10330183</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B63">
            <title>
               <p>Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Yamashita</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Andoh</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Ueno-Kudoh</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Sato</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Miyaki</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Asahara</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Exp Cell Res</source>
            <pubdate>2009</pubdate>
            <volume>315</volume>
            <fpage>2231</fpage>
            <lpage>2240</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.yexcr.2009.03.008</pubid>
                  <pubid idtype="pmcid">2696577</pubid>
                  <pubid idtype="pmpid" link="fulltext">19306868</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B64">
            <title>
               <p>Dominance of SOX9 function over RUNX2 during skeletogenesis</p>
            </title>
            <aug>
               <au>
                  <snm>Zhou</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Zheng</snm>
                  <fnm>Q</fnm>
               </au>
               <au>
                  <snm>Engin</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Munivez</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Chen</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Sebald</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Krakow</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Lee</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci USA</source>
            <pubdate>2006</pubdate>
            <volume>103</volume>
            <fpage>19004</fpage>
            <lpage>19009</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1073/pnas.0605170103</pubid>
                  <pubid idtype="pmcid">1748167</pubid>
                  <pubid idtype="pmpid" link="fulltext">17142326</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B65">
            <title>
               <p>Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Hill</snm>
                  <fnm>TP</fnm>
               </au>
               <au>
                  <snm>Spater</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Taketo</snm>
                  <fnm>MM</fnm>
               </au>
               <au>
                  <snm>Birchmeier</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Hartmann</snm>
                  <fnm>C</fnm>
               </au>
            </aug>
            <source>Dev Cell</source>
            <pubdate>2005</pubdate>
            <volume>8</volume>
            <fpage>727</fpage>
            <lpage>738</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.devcel.2005.02.013</pubid>
                  <pubid idtype="pmpid" link="fulltext">15866163</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B66">
            <title>
               <p>Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development</p>
            </title>
            <aug>
               <au>
                  <snm>Chung</snm>
                  <fnm>UI</fnm>
               </au>
               <au>
                  <snm>Schipani</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>McMahon</snm>
                  <fnm>AP</fnm>
               </au>
               <au>
                  <snm>Kronenberg</snm>
                  <fnm>HM</fnm>
               </au>
            </aug>
            <source>J Clin Invest</source>
            <pubdate>2001</pubdate>
            <volume>107</volume>
            <fpage>295</fpage>
            <lpage>304</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1172/JCI11706</pubid>
                  <pubid idtype="pmcid">199199</pubid>
                  <pubid idtype="pmpid" link="fulltext">11160153</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B67">
            <title>
               <p>The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones</p>
            </title>
            <aug>
               <au>
                  <snm>Huang</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Chung</snm>
                  <fnm>UI</fnm>
               </au>
               <au>
                  <snm>Kronenberg</snm>
                  <fnm>HM</fnm>
               </au>
               <au>
                  <snm>de Crombrugghe</snm>
                  <fnm>B</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci USA</source>
            <pubdate>2001</pubdate>
            <volume>98</volume>
            <fpage>160</fpage>
            <lpage>165</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1073/pnas.011393998</pubid>
                  <pubid idtype="pmcid">14561</pubid>
                  <pubid idtype="pmpid" link="fulltext">11120880</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B68">
            <title>
               <p>PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs</p>
            </title>
            <aug>
               <au>
                  <snm>Kim</snm>
                  <fnm>YJ</fnm>
               </au>
               <au>
                  <snm>Kim</snm>
                  <fnm>HJ</fnm>
               </au>
               <au>
                  <snm>Im</snm>
                  <fnm>GI</fnm>
               </au>
            </aug>
            <source>Biochem Biophys Res Commun</source>
            <pubdate>2008</pubdate>
            <volume>373</volume>
            <fpage>104</fpage>
            <lpage>108</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.bbrc.2008.05.183</pubid>
                  <pubid idtype="pmpid" link="fulltext">18554504</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B69">
            <title>
               <p>Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway</p>
            </title>
            <aug>
               <au>
                  <snm>Li</snm>
                  <fnm>TF</fnm>
               </au>
               <au>
                  <snm>Dong</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Ionescu</snm>
                  <fnm>AM</fnm>
               </au>
               <au>
                  <snm>Rosier</snm>
                  <fnm>RN</fnm>
               </au>
               <au>
                  <snm>Zuscik</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Schwarz</snm>
                  <fnm>EM</fnm>
               </au>
               <au>
                  <snm>O'Keefe</snm>
                  <fnm>RJ</fnm>
               </au>
               <au>
                  <snm>Drissi</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Exp Cell Res</source>
            <pubdate>2004</pubdate>
            <volume>299</volume>
            <fpage>128</fpage>
            <lpage>136</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.yexcr.2004.05.025</pubid>
                  <pubid idtype="pmpid" link="fulltext">15302580</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B70">
            <title>
               <p>Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein</p>
            </title>
            <aug>
               <au>
                  <snm>Vortkamp</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Lee</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Lanske</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Segre</snm>
                  <fnm>GV</fnm>
               </au>
               <au>
                  <snm>Kronenberg</snm>
                  <fnm>HM</fnm>
               </au>
               <au>
                  <snm>Tabin</snm>
                  <fnm>CJ</fnm>
               </au>
            </aug>
            <source>Science</source>
            <pubdate>1996</pubdate>
            <volume>273</volume>
            <fpage>613</fpage>
            <lpage>622</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1126/science.273.5275.613</pubid>
                  <pubid idtype="pmpid" link="fulltext">8662546</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B71">
            <title>
               <p>PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Wang</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Taboas</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Tuan</snm>
                  <fnm>RS</fnm>
               </au>
            </aug>
            <source>Osteoarthritis Cartilage</source>
            <pubdate>2011</pubdate>
            <volume>19</volume>
            <fpage>213</fpage>
            <lpage>221</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.joca.2010.11.003</pubid>
                  <pubid idtype="pmcid">3031753</pubid>
                  <pubid idtype="pmpid" link="fulltext">21087676</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B72">
            <title>
               <p>Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation</p>
            </title>
            <aug>
               <au>
                  <snm>Weir</snm>
                  <fnm>EC</fnm>
               </au>
               <au>
                  <snm>Philbrick</snm>
                  <fnm>WM</fnm>
               </au>
               <au>
                  <snm>Amling</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Neff</snm>
                  <fnm>LA</fnm>
               </au>
               <au>
                  <snm>Baron</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Broadus</snm>
                  <fnm>AE</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci USA</source>
            <pubdate>1996</pubdate>
            <volume>93</volume>
            <fpage>10240</fpage>
            <lpage>10245</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1073/pnas.93.19.10240</pubid>
                  <pubid idtype="pmcid">38368</pubid>
                  <pubid idtype="pmpid" link="fulltext">8816783</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B73">
            <title>
               <p>Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus</p>
            </title>
            <aug>
               <au>
                  <snm>Topol</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Chen</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Song</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Day</snm>
                  <fnm>TF</fnm>
               </au>
               <au>
                  <snm>Yang</snm>
                  <fnm>Y</fnm>
               </au>
            </aug>
            <source>J Biol Chem</source>
            <pubdate>2009</pubdate>
            <volume>284</volume>
            <fpage>3323</fpage>
            <lpage>3333</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">2631972</pubid>
                  <pubid idtype="pmpid" link="fulltext">19047045</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B74">
            <title>
               <p>Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate</p>
            </title>
            <aug>
               <au>
                  <snm>Smits</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Dy</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Mitra</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Lefebvre</snm>
                  <fnm>V</fnm>
               </au>
            </aug>
            <source>J Cell Biol</source>
            <pubdate>2004</pubdate>
            <volume>164</volume>
            <fpage>747</fpage>
            <lpage>758</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1083/jcb.200312045</pubid>
                  <pubid idtype="pmcid">2172159</pubid>
                  <pubid idtype="pmpid" link="fulltext">14993235</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B75">
            <title>
               <p>Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage</p>
            </title>
            <aug>
               <au>
                  <snm>Evans</snm>
                  <fnm>CH</fnm>
               </au>
               <au>
                  <snm>Liu</snm>
                  <fnm>FJ</fnm>
               </au>
               <au>
                  <snm>Glatt</snm>
                  <fnm>V</fnm>
               </au>
               <au>
                  <snm>Hoyland</snm>
                  <fnm>JA</fnm>
               </au>
               <au>
                  <snm>Kirker-Head</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Walsh</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Betz</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Wells</snm>
                  <fnm>JW</fnm>
               </au>
               <au>
                  <snm>Betz</snm>
                  <fnm>V</fnm>
               </au>
               <au>
                  <snm>Porter</snm>
                  <fnm>RM</fnm>
               </au>
               <au>
                  <snm>Saad</snm>
                  <fnm>FA</fnm>
               </au>
               <au>
                  <snm>Gerstenfeld</snm>
                  <fnm>LC</fnm>
               </au>
               <au>
                  <snm>Einhorn</snm>
                  <fnm>TA</fnm>
               </au>
               <au>
                  <snm>Harris</snm>
                  <fnm>MB</fnm>
               </au>
               <au>
                  <snm>Vrahas</snm>
                  <fnm>MS</fnm>
               </au>
            </aug>
            <source>Eur Cell Mater</source>
            <pubdate>2009</pubdate>
            <volume>18</volume>
            <fpage>96</fpage>
            <lpage>111</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">20073015</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B76">
            <title>
               <p>Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model</p>
            </title>
            <aug>
               <au>
                  <snm>Goodrich</snm>
                  <fnm>LR</fnm>
               </au>
               <au>
                  <snm>Hidaka</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Robbins</snm>
                  <fnm>PD</fnm>
               </au>
               <au>
                  <snm>Evans</snm>
                  <fnm>CH</fnm>
               </au>
               <au>
                  <snm>Nixon</snm>
                  <fnm>AJ</fnm>
               </au>
            </aug>
            <source>J Bone Joint Surg Br</source>
            <pubdate>2007</pubdate>
            <volume>89</volume>
            <fpage>672</fpage>
            <lpage>685</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">17540757</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B77">
            <title>
               <p>Articular cartilage repair by genetically modified bone marrow aspirate in sheep</p>
            </title>
            <aug>
               <au>
                  <snm>Ivkovic</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Pascher</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Hudetz</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Maticic</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Jelic</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Dickinson</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Loparic</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Haspl</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Windhager</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Pecina</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Gene</source>
            <pubdate>2010</pubdate>
            <volume>17</volume>
            <fpage>779</fpage>
            <lpage>789</lpage>
         </bibl>
         <bibl id="B78">
            <title>
               <p>Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells</p>
            </title>
            <aug>
               <au>
                  <snm>Kuroda</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Usas</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Kubo</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Corsi</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Peng</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Rose</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Cummins</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Fu</snm>
                  <fnm>FH</fnm>
               </au>
               <au>
                  <snm>Huard</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2006</pubdate>
            <volume>54</volume>
            <fpage>433</fpage>
            <lpage>442</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.21632</pubid>
                  <pubid idtype="pmpid" link="fulltext">16447218</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B79">
            <title>
               <p>Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model</p>
            </title>
            <aug>
               <au>
                  <snm>Menendez</snm>
                  <fnm>MI</fnm>
               </au>
               <au>
                  <snm>Clark</snm>
                  <fnm>DJ</fnm>
               </au>
               <au>
                  <snm>Carlton</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Flanigan</snm>
                  <fnm>DC</fnm>
               </au>
               <au>
                  <snm>Jia</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Sammet</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Weisbrode</snm>
                  <fnm>SE</fnm>
               </au>
               <au>
                  <snm>Knopp</snm>
                  <fnm>MV</fnm>
               </au>
               <au>
                  <snm>Bertone</snm>
                  <fnm>AL</fnm>
               </au>
            </aug>
            <source>Osteoarthritis Cartilage</source>
            <pubdate>2011</pubdate>
            <volume>19</volume>
            <fpage>1066</fpage>
            <lpage>1075</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.joca.2011.05.007</pubid>
                  <pubid idtype="pmpid" link="fulltext">21683796</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B80">
            <title>
               <p>IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects</p>
            </title>
            <aug>
               <au>
                  <snm>Morisset</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Frisbie</snm>
                  <fnm>DD</fnm>
               </au>
               <au>
                  <snm>Robbins</snm>
                  <fnm>PD</fnm>
               </au>
               <au>
                  <snm>Nixon</snm>
                  <fnm>AJ</fnm>
               </au>
               <au>
                  <snm>McIlwraith</snm>
                  <fnm>CW</fnm>
               </au>
            </aug>
            <source>Clin Orthop Relat Res</source>
            <pubdate>2007</pubdate>
            <volume>462</volume>
            <fpage>221</fpage>
            <lpage>228</lpage>
            <xrefbib>
               <pubid idtype="pmpid">17534189</pubid>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
